{
  "medication": "Vyvanse",
  "genericName": "lisdexamfetamine",
  "doseMg": null,
  "frequency": "as_recorded_in_app",
  "administrationPeriod": null,
  "startDay": "2026-01-01",
  "endDay": "2026-09-19",
  "source": "patient-reported history before 2026-09-01; app entries from 2026-09-01",
  "appRecordsStartDay": "2026-09-01",
  "historicalRegimen": {
    "doseMg": 60,
    "frequency": "daily",
    "administrationPeriod": "morning",
    "startDay": "2026-01-01",
    "endDay": "2026-08-31",
    "source": "patient-reported correction on 2026-08-29"
  },
  "timeZone": "America/Chicago",
  "exactTimePolicy": "Use each saved consumption time when available, otherwise its entry timestamp. Retain every recorded event time; do not infer timing for missing app entries.",
  "daily": [
    {
      "day": "2026-01-01",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-01-02",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-01-03",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-01-04",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-01-05",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-01-06",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-01-07",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-01-08",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-01-09",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-01-10",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-01-11",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-01-12",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-01-13",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-01-14",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-01-15",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-01-16",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-01-17",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-01-18",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-01-19",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-01-20",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-01-21",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-01-22",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-01-23",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-01-24",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-01-25",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-01-26",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-01-27",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-01-28",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-01-29",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-01-30",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-01-31",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-02-01",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-02-02",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-02-03",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-02-04",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-02-05",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-02-06",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-02-07",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-02-08",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-02-09",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-02-10",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-02-11",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-02-12",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-02-13",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-02-14",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-02-15",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-02-16",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-02-17",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-02-18",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-02-19",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-02-20",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-02-21",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-02-22",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-02-23",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-02-24",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-02-25",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-02-26",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-02-27",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-02-28",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-03-01",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-03-02",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-03-03",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-03-04",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-03-05",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-03-06",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-03-07",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-03-08",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-03-09",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-03-10",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-03-11",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-03-12",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-03-13",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-03-14",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-03-15",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-03-16",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-03-17",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-03-18",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-03-19",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-03-20",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-03-21",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-03-22",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-03-23",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-03-24",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-03-25",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-03-26",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-03-27",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-03-28",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-03-29",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-03-30",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-03-31",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-04-01",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-04-02",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-04-03",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-04-04",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-04-05",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-04-06",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-04-07",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-04-08",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-04-09",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-04-10",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-04-11",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-04-12",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-04-13",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-04-14",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-04-15",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-04-16",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-04-17",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-04-18",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-04-19",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-04-20",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-04-21",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-04-22",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-04-23",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-04-24",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-04-25",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-04-26",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-04-27",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-04-28",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-04-29",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-04-30",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-05-01",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-05-02",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-05-03",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-05-04",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-05-05",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-05-06",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-05-07",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-05-08",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-05-09",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-05-10",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-05-11",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-05-12",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-05-13",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-05-14",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-05-15",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-05-16",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-05-17",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-05-18",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-05-19",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-05-20",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-05-21",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-05-22",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-05-23",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-05-24",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-05-25",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-05-26",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-05-27",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-05-28",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-05-29",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-05-30",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-05-31",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-06-01",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-06-02",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-06-03",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-06-04",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-06-05",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-06-06",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-06-07",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-06-08",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-06-09",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-06-10",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-06-11",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-06-12",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-06-13",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-06-14",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-06-15",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-06-16",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-06-17",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-06-18",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-06-19",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-06-20",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-06-21",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-06-22",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-06-23",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-06-24",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-06-25",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-06-26",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-06-27",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-06-28",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-06-29",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-06-30",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-07-01",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "6:57 AM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "6:57 AM",
      "recorded_dose_components_mg": "60",
      "recorded_dose_component_sum_mg": 60,
      "reconciliation_status": "single_60mg_record_with_exact_time",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-07-02",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "12:04 AM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "12:04 AM",
      "recorded_dose_components_mg": "60",
      "recorded_dose_component_sum_mg": 60,
      "reconciliation_status": "single_60mg_record_with_exact_time",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-07-03",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "12:24 AM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "12:24 AM",
      "recorded_dose_components_mg": "60",
      "recorded_dose_component_sum_mg": 60,
      "reconciliation_status": "single_60mg_record_with_exact_time",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-07-04",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "4:37 AM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "4:37 AM",
      "recorded_dose_components_mg": "60",
      "recorded_dose_component_sum_mg": 60,
      "reconciliation_status": "single_60mg_record_with_exact_time",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-07-05",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "12:57 AM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "12:57 AM",
      "recorded_dose_components_mg": "60",
      "recorded_dose_component_sum_mg": 60,
      "reconciliation_status": "single_60mg_record_with_exact_time",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-07-06",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "9:36 AM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "9:36 AM",
      "recorded_dose_components_mg": "60",
      "recorded_dose_component_sum_mg": 60,
      "reconciliation_status": "single_60mg_record_with_exact_time",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-07-07",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "12:00 AM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "12:00 AM",
      "recorded_dose_components_mg": "60",
      "recorded_dose_component_sum_mg": 60,
      "reconciliation_status": "single_60mg_record_with_exact_time",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-07-08",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "12:14 AM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "12:14 AM",
      "recorded_dose_components_mg": "60",
      "recorded_dose_component_sum_mg": 60,
      "reconciliation_status": "single_60mg_record_with_exact_time",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-07-09",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "1:42 AM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "1:42 AM",
      "recorded_dose_components_mg": "60",
      "recorded_dose_component_sum_mg": 60,
      "reconciliation_status": "single_60mg_record_with_exact_time",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-07-10",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "12:45 AM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "12:45 AM",
      "recorded_dose_components_mg": "60",
      "recorded_dose_component_sum_mg": 60,
      "reconciliation_status": "single_60mg_record_with_exact_time",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-07-11",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "6:16 AM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "6:16 AM",
      "recorded_dose_components_mg": "60",
      "recorded_dose_component_sum_mg": 60,
      "reconciliation_status": "single_60mg_record_with_exact_time",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-07-12",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "12:12 AM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "12:12 AM",
      "recorded_dose_components_mg": "60",
      "recorded_dose_component_sum_mg": 60,
      "reconciliation_status": "single_60mg_record_with_exact_time",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-07-13",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "2:51 AM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "2:51 AM",
      "recorded_dose_components_mg": "60",
      "recorded_dose_component_sum_mg": 60,
      "reconciliation_status": "single_60mg_record_with_exact_time",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-07-14",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "3:53 AM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "3:53 AM",
      "recorded_dose_components_mg": "60",
      "recorded_dose_component_sum_mg": 60,
      "reconciliation_status": "single_60mg_record_with_exact_time",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-07-15",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "6:35 AM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "6:35 AM",
      "recorded_dose_components_mg": "60",
      "recorded_dose_component_sum_mg": 60,
      "reconciliation_status": "single_60mg_record_with_exact_time",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-07-16",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 2,
      "recorded_event_times": "8:52 AM|12:24 PM",
      "recorded_dose_components_mg": "20|20",
      "recorded_dose_component_sum_mg": 40,
      "reconciliation_status": "recorded_events_conflict_or_duplicate_patient_correction_is_60mg_daily",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-07-17",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "12:41 PM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "12:41 PM",
      "recorded_dose_components_mg": "20",
      "recorded_dose_component_sum_mg": 20,
      "reconciliation_status": "recorded_events_conflict_or_duplicate_patient_correction_is_60mg_daily",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-07-18",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 2,
      "recorded_event_times": "9:19 AM|12:50 PM",
      "recorded_dose_components_mg": "20|20",
      "recorded_dose_component_sum_mg": 40,
      "reconciliation_status": "recorded_events_conflict_or_duplicate_patient_correction_is_60mg_daily",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-07-19",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 2,
      "recorded_event_times": "12:20 PM|12:20 PM",
      "recorded_dose_components_mg": "20|20",
      "recorded_dose_component_sum_mg": 40,
      "reconciliation_status": "recorded_events_conflict_or_duplicate_patient_correction_is_60mg_daily",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-07-20",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 2,
      "recorded_event_times": "6:55 AM|1:23 PM",
      "recorded_dose_components_mg": "20|20",
      "recorded_dose_component_sum_mg": 40,
      "reconciliation_status": "recorded_events_conflict_or_duplicate_patient_correction_is_60mg_daily",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-07-21",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 2,
      "recorded_event_times": "10:55 AM|10:55 AM",
      "recorded_dose_components_mg": "20|20",
      "recorded_dose_component_sum_mg": 40,
      "reconciliation_status": "recorded_events_conflict_or_duplicate_patient_correction_is_60mg_daily",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-07-22",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 2,
      "recorded_event_times": "2:13 PM|2:13 PM",
      "recorded_dose_components_mg": "20|20",
      "recorded_dose_component_sum_mg": 40,
      "reconciliation_status": "recorded_events_conflict_or_duplicate_patient_correction_is_60mg_daily",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-07-23",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 2,
      "recorded_event_times": "7:57 AM|7:57 AM",
      "recorded_dose_components_mg": "20|20",
      "recorded_dose_component_sum_mg": 40,
      "reconciliation_status": "recorded_events_conflict_or_duplicate_patient_correction_is_60mg_daily",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-07-24",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-07-25",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 2,
      "recorded_event_times": "10:32 AM|10:33 AM",
      "recorded_dose_components_mg": "20|20",
      "recorded_dose_component_sum_mg": 40,
      "reconciliation_status": "recorded_events_conflict_or_duplicate_patient_correction_is_60mg_daily",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-07-26",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "5:11 PM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "5:11 PM",
      "recorded_dose_components_mg": "20",
      "recorded_dose_component_sum_mg": 20,
      "reconciliation_status": "recorded_events_conflict_or_duplicate_patient_correction_is_60mg_daily",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-07-27",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 2,
      "recorded_event_times": "10:36 AM|10:36 AM",
      "recorded_dose_components_mg": "20|20",
      "recorded_dose_component_sum_mg": 40,
      "reconciliation_status": "recorded_events_conflict_or_duplicate_patient_correction_is_60mg_daily",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-07-28",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 2,
      "recorded_event_times": "10:32 AM|10:32 AM",
      "recorded_dose_components_mg": "20|20",
      "recorded_dose_component_sum_mg": 40,
      "reconciliation_status": "recorded_events_conflict_or_duplicate_patient_correction_is_60mg_daily",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-07-29",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-07-30",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 2,
      "recorded_event_times": "1:50 PM|1:50 PM",
      "recorded_dose_components_mg": "20|20",
      "recorded_dose_component_sum_mg": 40,
      "reconciliation_status": "recorded_events_conflict_or_duplicate_patient_correction_is_60mg_daily",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-07-31",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 2,
      "recorded_event_times": "7:40 AM|7:45 AM",
      "recorded_dose_components_mg": "20|20",
      "recorded_dose_component_sum_mg": 40,
      "reconciliation_status": "recorded_events_conflict_or_duplicate_patient_correction_is_60mg_daily",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-08-01",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 2,
      "recorded_event_times": "9:39 AM|9:39 AM",
      "recorded_dose_components_mg": "20|20",
      "recorded_dose_component_sum_mg": 40,
      "reconciliation_status": "recorded_events_conflict_or_duplicate_patient_correction_is_60mg_daily",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-08-02",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 2,
      "recorded_event_times": "6:34 AM|8:00 AM",
      "recorded_dose_components_mg": "20|40",
      "recorded_dose_component_sum_mg": 60,
      "reconciliation_status": "recorded_components_sum_to_60mg",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-08-03",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "10:54 AM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "10:54 AM",
      "recorded_dose_components_mg": "20",
      "recorded_dose_component_sum_mg": 20,
      "reconciliation_status": "recorded_events_conflict_or_duplicate_patient_correction_is_60mg_daily",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-08-04",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "6:26 AM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "6:26 AM",
      "recorded_dose_components_mg": "20",
      "recorded_dose_component_sum_mg": 20,
      "reconciliation_status": "recorded_events_conflict_or_duplicate_patient_correction_is_60mg_daily",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-08-05",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "2:19 PM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "2:19 PM",
      "recorded_dose_components_mg": "20",
      "recorded_dose_component_sum_mg": 20,
      "reconciliation_status": "recorded_events_conflict_or_duplicate_patient_correction_is_60mg_daily",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-08-06",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "8:58 AM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "8:58 AM",
      "recorded_dose_components_mg": "60",
      "recorded_dose_component_sum_mg": 60,
      "reconciliation_status": "single_60mg_record_with_exact_time",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-08-07",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-08-08",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "12:00 PM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "12:00 PM",
      "recorded_dose_components_mg": "60",
      "recorded_dose_component_sum_mg": 60,
      "reconciliation_status": "single_60mg_record_with_exact_time",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-08-09",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-08-10",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "6:32 AM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "6:32 AM",
      "recorded_dose_components_mg": "60",
      "recorded_dose_component_sum_mg": 60,
      "reconciliation_status": "single_60mg_record_with_exact_time",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-08-11",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "2:22 PM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "2:22 PM",
      "recorded_dose_components_mg": "60",
      "recorded_dose_component_sum_mg": 60,
      "reconciliation_status": "single_60mg_record_with_exact_time",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-08-12",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "9:12 AM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "9:12 AM",
      "recorded_dose_components_mg": "60",
      "recorded_dose_component_sum_mg": 60,
      "reconciliation_status": "single_60mg_record_with_exact_time",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-08-13",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "12:59 PM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "12:59 PM",
      "recorded_dose_components_mg": "60",
      "recorded_dose_component_sum_mg": 60,
      "reconciliation_status": "single_60mg_record_with_exact_time",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-08-14",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-08-15",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "11:17 AM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "11:17 AM",
      "recorded_dose_components_mg": "60",
      "recorded_dose_component_sum_mg": 60,
      "reconciliation_status": "single_60mg_record_with_exact_time",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-08-16",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "11:15 AM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "11:15 AM",
      "recorded_dose_components_mg": "60",
      "recorded_dose_component_sum_mg": 60,
      "reconciliation_status": "single_60mg_record_with_exact_time",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-08-17",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "10:28 AM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "10:28 AM",
      "recorded_dose_components_mg": "60",
      "recorded_dose_component_sum_mg": 60,
      "reconciliation_status": "single_60mg_record_with_exact_time",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-08-18",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-08-19",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "11:51 AM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "11:51 AM",
      "recorded_dose_components_mg": "60",
      "recorded_dose_component_sum_mg": 60,
      "reconciliation_status": "single_60mg_record_with_exact_time",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-08-20",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "10:29 AM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "10:29 AM",
      "recorded_dose_components_mg": "60",
      "recorded_dose_component_sum_mg": 60,
      "reconciliation_status": "single_60mg_record_with_exact_time",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-08-21",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "11:44 AM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "11:44 AM",
      "recorded_dose_components_mg": "60",
      "recorded_dose_component_sum_mg": 60,
      "reconciliation_status": "single_60mg_record_with_exact_time",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-08-22",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-08-23",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "11:22 AM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "11:22 AM",
      "recorded_dose_components_mg": "60",
      "recorded_dose_component_sum_mg": 60,
      "reconciliation_status": "single_60mg_record_with_exact_time",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-08-24",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "11:03 AM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "11:03 AM",
      "recorded_dose_components_mg": "60",
      "recorded_dose_component_sum_mg": 60,
      "reconciliation_status": "single_60mg_record_with_exact_time",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-08-25",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-08-26",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "11:22 AM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "11:22 AM",
      "recorded_dose_components_mg": "60",
      "recorded_dose_component_sum_mg": 60,
      "reconciliation_status": "single_60mg_record_with_exact_time",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-08-27",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-08-28",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "patient_reported_daily_regimen_exact_time_unrecorded",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-08-29",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "12:03 PM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "12:03 PM",
      "recorded_dose_components_mg": "60",
      "recorded_dose_component_sum_mg": 60,
      "reconciliation_status": "single_60mg_record_with_exact_time",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-08-30",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "7:33 AM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "7:33 AM",
      "recorded_dose_components_mg": "60",
      "recorded_dose_component_sum_mg": 60,
      "reconciliation_status": "single_60mg_record_with_exact_time",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-08-31",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": 60,
      "patient_reported_period": "morning",
      "exact_time": "11:12 AM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "11:12 AM",
      "recorded_dose_components_mg": "60",
      "recorded_dose_component_sum_mg": 60,
      "reconciliation_status": "single_60mg_record_with_exact_time",
      "evidence": "Patient-reported correction on 2026-08-29: 60 mg every morning from 2026-01-01 through 2026-08-31.",
      "effective_daily_dose_mg": 60,
      "data_source": "patient_reported_regimen"
    },
    {
      "day": "2026-09-01",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": null,
      "patient_reported_period": "",
      "exact_time": "11:12 AM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "11:12 AM",
      "recorded_dose_components_mg": "60",
      "recorded_dose_component_sum_mg": 60,
      "reconciliation_status": "app_recorded",
      "evidence": "App entries are authoritative from 2026-09-01; saved consumption times take precedence over logging times. A missing entry does not establish whether medication was taken.",
      "effective_daily_dose_mg": 60,
      "data_source": "app_recorded"
    },
    {
      "day": "2026-09-02",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": null,
      "patient_reported_period": "",
      "exact_time": "1:44 PM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "1:44 PM",
      "recorded_dose_components_mg": "60",
      "recorded_dose_component_sum_mg": 60,
      "reconciliation_status": "app_recorded",
      "evidence": "App entries are authoritative from 2026-09-01; saved consumption times take precedence over logging times. A missing entry does not establish whether medication was taken.",
      "effective_daily_dose_mg": 60,
      "data_source": "app_recorded"
    },
    {
      "day": "2026-09-03",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": null,
      "patient_reported_period": "",
      "exact_time": "12:08 PM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "12:08 PM",
      "recorded_dose_components_mg": "60",
      "recorded_dose_component_sum_mg": 60,
      "reconciliation_status": "app_recorded",
      "evidence": "App entries are authoritative from 2026-09-01; saved consumption times take precedence over logging times. A missing entry does not establish whether medication was taken.",
      "effective_daily_dose_mg": 60,
      "data_source": "app_recorded"
    },
    {
      "day": "2026-09-04",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": null,
      "patient_reported_period": "",
      "exact_time": "11:45 AM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "11:45 AM",
      "recorded_dose_components_mg": "60",
      "recorded_dose_component_sum_mg": 60,
      "reconciliation_status": "app_recorded",
      "evidence": "App entries are authoritative from 2026-09-01; saved consumption times take precedence over logging times. A missing entry does not establish whether medication was taken.",
      "effective_daily_dose_mg": 60,
      "data_source": "app_recorded"
    },
    {
      "day": "2026-09-05",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": null,
      "patient_reported_period": "",
      "exact_time": "12:10 PM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "12:10 PM",
      "recorded_dose_components_mg": "60",
      "recorded_dose_component_sum_mg": 60,
      "reconciliation_status": "app_recorded",
      "evidence": "App entries are authoritative from 2026-09-01; saved consumption times take precedence over logging times. A missing entry does not establish whether medication was taken.",
      "effective_daily_dose_mg": 60,
      "data_source": "app_recorded"
    },
    {
      "day": "2026-09-06",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": null,
      "patient_reported_period": "",
      "exact_time": "6:26 PM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "6:26 PM",
      "recorded_dose_components_mg": "20",
      "recorded_dose_component_sum_mg": 20,
      "reconciliation_status": "app_recorded",
      "evidence": "App entries are authoritative from 2026-09-01; saved consumption times take precedence over logging times. A missing entry does not establish whether medication was taken.",
      "effective_daily_dose_mg": 20,
      "data_source": "app_recorded"
    },
    {
      "day": "2026-09-07",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": null,
      "patient_reported_period": "",
      "exact_time": "12:57 PM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "12:57 PM",
      "recorded_dose_components_mg": "20",
      "recorded_dose_component_sum_mg": 20,
      "reconciliation_status": "app_recorded",
      "evidence": "App entries are authoritative from 2026-09-01; saved consumption times take precedence over logging times. A missing entry does not establish whether medication was taken.",
      "effective_daily_dose_mg": 20,
      "data_source": "app_recorded"
    },
    {
      "day": "2026-09-08",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": null,
      "patient_reported_period": "",
      "exact_time": "2:42 PM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "2:42 PM",
      "recorded_dose_components_mg": "20",
      "recorded_dose_component_sum_mg": 20,
      "reconciliation_status": "app_recorded",
      "evidence": "App entries are authoritative from 2026-09-01; saved consumption times take precedence over logging times. A missing entry does not establish whether medication was taken.",
      "effective_daily_dose_mg": 20,
      "data_source": "app_recorded"
    },
    {
      "day": "2026-09-09",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": null,
      "patient_reported_period": "",
      "exact_time": "1:25 PM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "1:25 PM",
      "recorded_dose_components_mg": "20",
      "recorded_dose_component_sum_mg": 20,
      "reconciliation_status": "app_recorded",
      "evidence": "App entries are authoritative from 2026-09-01; saved consumption times take precedence over logging times. A missing entry does not establish whether medication was taken.",
      "effective_daily_dose_mg": 20,
      "data_source": "app_recorded"
    },
    {
      "day": "2026-09-10",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": null,
      "patient_reported_period": "",
      "exact_time": "2:23 PM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "2:23 PM",
      "recorded_dose_components_mg": "20",
      "recorded_dose_component_sum_mg": 20,
      "reconciliation_status": "app_recorded",
      "evidence": "App entries are authoritative from 2026-09-01; saved consumption times take precedence over logging times. A missing entry does not establish whether medication was taken.",
      "effective_daily_dose_mg": 20,
      "data_source": "app_recorded"
    },
    {
      "day": "2026-09-11",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": null,
      "patient_reported_period": "",
      "exact_time": "1:11 PM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "1:11 PM",
      "recorded_dose_components_mg": "20",
      "recorded_dose_component_sum_mg": 20,
      "reconciliation_status": "app_recorded",
      "evidence": "App entries are authoritative from 2026-09-01; saved consumption times take precedence over logging times. A missing entry does not establish whether medication was taken.",
      "effective_daily_dose_mg": 20,
      "data_source": "app_recorded"
    },
    {
      "day": "2026-09-12",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": null,
      "patient_reported_period": "",
      "exact_time": "1:44 PM",
      "exact_time_recorded": "yes",
      "recorded_event_count": 1,
      "recorded_event_times": "1:44 PM",
      "recorded_dose_components_mg": "20",
      "recorded_dose_component_sum_mg": 20,
      "reconciliation_status": "app_recorded",
      "evidence": "App entries are authoritative from 2026-09-01; saved consumption times take precedence over logging times. A missing entry does not establish whether medication was taken.",
      "effective_daily_dose_mg": 20,
      "data_source": "app_recorded"
    },
    {
      "day": "2026-09-13",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": null,
      "patient_reported_period": "",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "app_not_recorded",
      "evidence": "App entries are authoritative from 2026-09-01; saved consumption times take precedence over logging times. A missing entry does not establish whether medication was taken.",
      "effective_daily_dose_mg": null,
      "data_source": "app_not_recorded"
    },
    {
      "day": "2026-09-14",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": null,
      "patient_reported_period": "",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "app_not_recorded",
      "evidence": "App entries are authoritative from 2026-09-01; saved consumption times take precedence over logging times. A missing entry does not establish whether medication was taken.",
      "effective_daily_dose_mg": null,
      "data_source": "app_not_recorded"
    },
    {
      "day": "2026-09-15",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": null,
      "patient_reported_period": "",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "app_not_recorded",
      "evidence": "App entries are authoritative from 2026-09-01; saved consumption times take precedence over logging times. A missing entry does not establish whether medication was taken.",
      "effective_daily_dose_mg": null,
      "data_source": "app_not_recorded"
    },
    {
      "day": "2026-09-16",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": null,
      "patient_reported_period": "",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "app_not_recorded",
      "evidence": "App entries are authoritative from 2026-09-01; saved consumption times take precedence over logging times. A missing entry does not establish whether medication was taken.",
      "effective_daily_dose_mg": null,
      "data_source": "app_not_recorded"
    },
    {
      "day": "2026-09-17",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": null,
      "patient_reported_period": "",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "app_not_recorded",
      "evidence": "App entries are authoritative from 2026-09-01; saved consumption times take precedence over logging times. A missing entry does not establish whether medication was taken.",
      "effective_daily_dose_mg": null,
      "data_source": "app_not_recorded"
    },
    {
      "day": "2026-09-18",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": null,
      "patient_reported_period": "",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "app_not_recorded",
      "evidence": "App entries are authoritative from 2026-09-01; saved consumption times take precedence over logging times. A missing entry does not establish whether medication was taken.",
      "effective_daily_dose_mg": null,
      "data_source": "app_not_recorded"
    },
    {
      "day": "2026-09-19",
      "medication": "Vyvanse",
      "generic_name": "lisdexamfetamine",
      "patient_reported_daily_dose_mg": null,
      "patient_reported_period": "",
      "exact_time": "",
      "exact_time_recorded": "no",
      "recorded_event_count": 0,
      "recorded_event_times": "",
      "recorded_dose_components_mg": "",
      "recorded_dose_component_sum_mg": null,
      "reconciliation_status": "app_not_recorded",
      "evidence": "App entries are authoritative from 2026-09-01; saved consumption times take precedence over logging times. A missing entry does not establish whether medication was taken.",
      "effective_daily_dose_mg": null,
      "data_source": "app_not_recorded"
    }
  ],
  "recordedEvents": [
    {
      "day": "2026-07-01",
      "recorded_timestamp": "2026-07-01T11:57:09.222Z",
      "local_time": "6:57 AM",
      "meal_id": "9A5DC0E3-E631-4D62-9D3B-0E4EB21018FC",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 60,
      "recorded_unit": "mg",
      "meal_name": "Daily Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":60,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"createdAt\":\"2026-07-01T11:57:09.222Z\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system (CNS) stimulant used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. It contains one active ingredient: Lisdexamfetamine dimesylate (60 mg per dose). This is a 'prodrug,' meaning it is biologically inactive when swallowed and is converted by enzymes in the blood into its active form, dextroamphetamine, which helps increase levels of dopamine and norepinephrine in the brain. Vyvanse is a controlled substance with a potential for abuse and dependence. It is not a source of dietary nutrients. Common side effects may include insomnia, decreased appetite, dry mouth, and increased heart rate. This information is for educational purposes and does not constitute medical advice; always consult your healthcare provider regarding medication use.\",\"gramWeight\":0.06,\"hiddenFromFriends\":true,\"id\":\"47AAC4F8-45C0-46C8-8E0E-23C621F6B5D0\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"60 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":60,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-01T11:57:09.222Z\",\"useCount\":0}",
      "consumed_timestamp": "",
      "timestamp_source": "recorded_timestamp"
    },
    {
      "day": "2026-07-02",
      "recorded_timestamp": "2026-07-02T05:04:22.513Z",
      "local_time": "12:04 AM",
      "meal_id": "B481E116-31F1-4192-B3D2-361D79E6B79D",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 60,
      "recorded_unit": "mg",
      "meal_name": "Daily Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":60,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"createdAt\":\"2026-07-02T05:04:22.513Z\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system (CNS) stimulant used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. It contains one active ingredient: Lisdexamfetamine dimesylate (60 mg per dose). This is a 'prodrug,' meaning it is biologically inactive when swallowed and is converted by enzymes in the blood into its active form, dextroamphetamine, which helps increase levels of dopamine and norepinephrine in the brain. Vyvanse is a controlled substance with a potential for abuse and dependence. It is not a source of dietary nutrients. Common side effects may include insomnia, decreased appetite, dry mouth, and increased heart rate. This information is for educational purposes and does not constitute medical advice; always consult your healthcare provider regarding medication use.\",\"gramWeight\":0.06,\"hiddenFromFriends\":true,\"id\":\"472A218C-49C5-4975-98C9-B3A13B5DE322\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"60 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":60,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-02T05:04:22.513Z\",\"useCount\":0}",
      "consumed_timestamp": "",
      "timestamp_source": "recorded_timestamp"
    },
    {
      "day": "2026-07-03",
      "recorded_timestamp": "2026-07-03T05:24:13.508Z",
      "local_time": "12:24 AM",
      "meal_id": "3666A50E-52B2-4368-9608-0CEE00685907",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 60,
      "recorded_unit": "mg",
      "meal_name": "Daily Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":60,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"createdAt\":\"2026-07-03T05:24:13.508Z\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system (CNS) stimulant used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. It contains one active ingredient: Lisdexamfetamine dimesylate (60 mg per dose). This is a 'prodrug,' meaning it is biologically inactive when swallowed and is converted by enzymes in the blood into its active form, dextroamphetamine, which helps increase levels of dopamine and norepinephrine in the brain. Vyvanse is a controlled substance with a potential for abuse and dependence. It is not a source of dietary nutrients. Common side effects may include insomnia, decreased appetite, dry mouth, and increased heart rate. This information is for educational purposes and does not constitute medical advice; always consult your healthcare provider regarding medication use.\",\"gramWeight\":0.06,\"hiddenFromFriends\":true,\"id\":\"A9D882D5-EFAF-40D9-9FCD-FF698DD8C6D2\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"60 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":60,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-03T05:24:13.508Z\",\"useCount\":0}",
      "consumed_timestamp": "",
      "timestamp_source": "recorded_timestamp"
    },
    {
      "day": "2026-07-04",
      "recorded_timestamp": "2026-07-04T09:37:12.368Z",
      "local_time": "4:37 AM",
      "meal_id": "54B12DD7-2199-4AA5-9931-F8DA21A58FDB",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 60,
      "recorded_unit": "mg",
      "meal_name": "Daily Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":60,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"createdAt\":\"2026-07-04T09:37:12.368Z\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system (CNS) stimulant used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. It contains one active ingredient: Lisdexamfetamine dimesylate (60 mg per dose). This is a 'prodrug,' meaning it is biologically inactive when swallowed and is converted by enzymes in the blood into its active form, dextroamphetamine, which helps increase levels of dopamine and norepinephrine in the brain. Vyvanse is a controlled substance with a potential for abuse and dependence. It is not a source of dietary nutrients. Common side effects may include insomnia, decreased appetite, dry mouth, and increased heart rate. This information is for educational purposes and does not constitute medical advice; always consult your healthcare provider regarding medication use.\",\"gramWeight\":0.06,\"hiddenFromFriends\":true,\"id\":\"21F88697-27DA-41C0-A2A6-E3B855F42E1F\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"60 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":60,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-04T09:37:12.368Z\",\"useCount\":0}",
      "consumed_timestamp": "",
      "timestamp_source": "recorded_timestamp"
    },
    {
      "day": "2026-07-05",
      "recorded_timestamp": "2026-07-05T05:57:21.855Z",
      "local_time": "12:57 AM",
      "meal_id": "B44249C9-492E-4892-8231-CEA21154301D",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 60,
      "recorded_unit": "mg",
      "meal_name": "Daily Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":60,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"createdAt\":\"2026-07-05T05:57:21.855Z\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system (CNS) stimulant used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. It contains one active ingredient: Lisdexamfetamine dimesylate (60 mg per dose). This is a 'prodrug,' meaning it is biologically inactive when swallowed and is converted by enzymes in the blood into its active form, dextroamphetamine, which helps increase levels of dopamine and norepinephrine in the brain. Vyvanse is a controlled substance with a potential for abuse and dependence. It is not a source of dietary nutrients. Common side effects may include insomnia, decreased appetite, dry mouth, and increased heart rate. This information is for educational purposes and does not constitute medical advice; always consult your healthcare provider regarding medication use.\",\"gramWeight\":0.06,\"hiddenFromFriends\":true,\"id\":\"EE9945D9-39F9-4FB9-BCB2-57AB2344F996\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"60 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":60,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-05T05:57:21.855Z\",\"useCount\":0}",
      "consumed_timestamp": "",
      "timestamp_source": "recorded_timestamp"
    },
    {
      "day": "2026-07-06",
      "recorded_timestamp": "2026-07-06T14:36:37.453Z",
      "local_time": "9:36 AM",
      "meal_id": "E8627661-9C14-4352-A8D1-906C640FCE5B",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 60,
      "recorded_unit": "mg",
      "meal_name": "Daily Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":60,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"createdAt\":\"2026-07-06T14:36:37.453Z\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system (CNS) stimulant used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. It contains one active ingredient: Lisdexamfetamine dimesylate (60 mg per dose). This is a 'prodrug,' meaning it is biologically inactive when swallowed and is converted by enzymes in the blood into its active form, dextroamphetamine, which helps increase levels of dopamine and norepinephrine in the brain. Vyvanse is a controlled substance with a potential for abuse and dependence. It is not a source of dietary nutrients. Common side effects may include insomnia, decreased appetite, dry mouth, and increased heart rate. This information is for educational purposes and does not constitute medical advice; always consult your healthcare provider regarding medication use.\",\"gramWeight\":0.06,\"hiddenFromFriends\":true,\"id\":\"E7968AF8-3482-4B4F-A951-C88134D20743\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"60 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":60,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-06T14:36:37.453Z\",\"useCount\":0}",
      "consumed_timestamp": "",
      "timestamp_source": "recorded_timestamp"
    },
    {
      "day": "2026-07-07",
      "recorded_timestamp": "2026-07-07T05:00:48.607Z",
      "local_time": "12:00 AM",
      "meal_id": "3A187CC0-34A2-40C6-88F5-DAD39B9B3418",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 60,
      "recorded_unit": "mg",
      "meal_name": "Daily Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":60,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"createdAt\":\"2026-07-07T05:00:48.607Z\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system (CNS) stimulant used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. It contains one active ingredient: Lisdexamfetamine dimesylate (60 mg per dose). This is a 'prodrug,' meaning it is biologically inactive when swallowed and is converted by enzymes in the blood into its active form, dextroamphetamine, which helps increase levels of dopamine and norepinephrine in the brain. Vyvanse is a controlled substance with a potential for abuse and dependence. It is not a source of dietary nutrients. Common side effects may include insomnia, decreased appetite, dry mouth, and increased heart rate. This information is for educational purposes and does not constitute medical advice; always consult your healthcare provider regarding medication use.\",\"gramWeight\":0.06,\"hiddenFromFriends\":true,\"id\":\"8C795D25-4E9C-4A05-8ABD-4B15FF93E696\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"60 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":60,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-07T05:00:48.607Z\",\"useCount\":0}",
      "consumed_timestamp": "",
      "timestamp_source": "recorded_timestamp"
    },
    {
      "day": "2026-07-08",
      "recorded_timestamp": "2026-07-08T05:14:25.732Z",
      "local_time": "12:14 AM",
      "meal_id": "F57BDED6-2A74-4D79-8850-6838B9291F24",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 60,
      "recorded_unit": "mg",
      "meal_name": "Daily Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":60,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"createdAt\":\"2026-07-08T05:14:25.732Z\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system (CNS) stimulant used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. It contains one active ingredient: Lisdexamfetamine dimesylate (60 mg per dose). This is a 'prodrug,' meaning it is biologically inactive when swallowed and is converted by enzymes in the blood into its active form, dextroamphetamine, which helps increase levels of dopamine and norepinephrine in the brain. Vyvanse is a controlled substance with a potential for abuse and dependence. It is not a source of dietary nutrients. Common side effects may include insomnia, decreased appetite, dry mouth, and increased heart rate. This information is for educational purposes and does not constitute medical advice; always consult your healthcare provider regarding medication use.\",\"gramWeight\":0.06,\"hiddenFromFriends\":true,\"id\":\"E634FF03-D7FD-4F25-A610-F79F6E411340\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"60 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":60,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-08T05:14:25.732Z\",\"useCount\":0}",
      "consumed_timestamp": "",
      "timestamp_source": "recorded_timestamp"
    },
    {
      "day": "2026-07-09",
      "recorded_timestamp": "2026-07-09T06:42:37.278Z",
      "local_time": "1:42 AM",
      "meal_id": "6BB27CF2-8DFB-4E6E-88AA-214AFBDDA9F9",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 60,
      "recorded_unit": "mg",
      "meal_name": "Daily Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":60,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"createdAt\":\"2026-07-09T06:42:37.278Z\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system (CNS) stimulant used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. It contains one active ingredient: Lisdexamfetamine dimesylate (60 mg per dose). This is a 'prodrug,' meaning it is biologically inactive when swallowed and is converted by enzymes in the blood into its active form, dextroamphetamine, which helps increase levels of dopamine and norepinephrine in the brain. Vyvanse is a controlled substance with a potential for abuse and dependence. It is not a source of dietary nutrients. Common side effects may include insomnia, decreased appetite, dry mouth, and increased heart rate. This information is for educational purposes and does not constitute medical advice; always consult your healthcare provider regarding medication use.\",\"gramWeight\":0.06,\"hiddenFromFriends\":true,\"id\":\"71AB1448-FB79-4E3A-B3EA-7BE3F7BC6169\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"60 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":60,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-09T06:42:37.278Z\",\"useCount\":0}",
      "consumed_timestamp": "",
      "timestamp_source": "recorded_timestamp"
    },
    {
      "day": "2026-07-10",
      "recorded_timestamp": "2026-07-10T05:45:34.096Z",
      "local_time": "12:45 AM",
      "meal_id": "A80E6118-BC96-46DD-9CEB-4B4237217B28",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 60,
      "recorded_unit": "mg",
      "meal_name": "Daily Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":60,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"createdAt\":\"2026-07-10T05:45:34.096Z\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system (CNS) stimulant used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. It contains one active ingredient: Lisdexamfetamine dimesylate (60 mg per dose). This is a 'prodrug,' meaning it is biologically inactive when swallowed and is converted by enzymes in the blood into its active form, dextroamphetamine, which helps increase levels of dopamine and norepinephrine in the brain. Vyvanse is a controlled substance with a potential for abuse and dependence. It is not a source of dietary nutrients. Common side effects may include insomnia, decreased appetite, dry mouth, and increased heart rate. This information is for educational purposes and does not constitute medical advice; always consult your healthcare provider regarding medication use.\",\"gramWeight\":0.06,\"hiddenFromFriends\":true,\"id\":\"E0B08272-A176-44B2-ABBB-F079A56DEC0E\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"60 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":60,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-10T05:45:34.096Z\",\"useCount\":0}",
      "consumed_timestamp": "",
      "timestamp_source": "recorded_timestamp"
    },
    {
      "day": "2026-07-11",
      "recorded_timestamp": "2026-07-11T11:16:49.936Z",
      "local_time": "6:16 AM",
      "meal_id": "458B45D3-508C-411A-88CE-D29DAB7F232D",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 60,
      "recorded_unit": "mg",
      "meal_name": "Daily Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":60,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"createdAt\":\"2026-07-11T11:16:49.936Z\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system (CNS) stimulant used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. It contains one active ingredient: Lisdexamfetamine dimesylate (60 mg per dose). This is a 'prodrug,' meaning it is biologically inactive when swallowed and is converted by enzymes in the blood into its active form, dextroamphetamine, which helps increase levels of dopamine and norepinephrine in the brain. Vyvanse is a controlled substance with a potential for abuse and dependence. It is not a source of dietary nutrients. Common side effects may include insomnia, decreased appetite, dry mouth, and increased heart rate. This information is for educational purposes and does not constitute medical advice; always consult your healthcare provider regarding medication use.\",\"gramWeight\":0.06,\"hiddenFromFriends\":true,\"id\":\"ADFD9AC3-F8E8-4F06-BCE0-A1AB7AB8393F\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"60 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":60,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-11T11:16:49.936Z\",\"useCount\":0}",
      "consumed_timestamp": "",
      "timestamp_source": "recorded_timestamp"
    },
    {
      "day": "2026-07-12",
      "recorded_timestamp": "2026-07-12T05:12:35.949Z",
      "local_time": "12:12 AM",
      "meal_id": "92E5CCC0-4FB4-4E89-B039-3F61CD1E76F4",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 60,
      "recorded_unit": "mg",
      "meal_name": "Daily Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":60,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"createdAt\":\"2026-07-12T05:12:35.949Z\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system (CNS) stimulant used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. It contains one active ingredient: Lisdexamfetamine dimesylate (60 mg per dose). This is a 'prodrug,' meaning it is biologically inactive when swallowed and is converted by enzymes in the blood into its active form, dextroamphetamine, which helps increase levels of dopamine and norepinephrine in the brain. Vyvanse is a controlled substance with a potential for abuse and dependence. It is not a source of dietary nutrients. Common side effects may include insomnia, decreased appetite, dry mouth, and increased heart rate. This information is for educational purposes and does not constitute medical advice; always consult your healthcare provider regarding medication use.\",\"gramWeight\":0.06,\"hiddenFromFriends\":true,\"id\":\"E38FFBF1-3B47-468A-A802-BA76940B2F49\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"60 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":60,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-12T05:12:35.949Z\",\"useCount\":0}",
      "consumed_timestamp": "",
      "timestamp_source": "recorded_timestamp"
    },
    {
      "day": "2026-07-13",
      "recorded_timestamp": "2026-07-13T07:51:35.179Z",
      "local_time": "2:51 AM",
      "meal_id": "7C819DE0-0A81-48BB-8778-EFD52D644C6E",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 60,
      "recorded_unit": "mg",
      "meal_name": "Daily Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":60,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"createdAt\":\"2026-07-13T07:51:35.179Z\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system (CNS) stimulant used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. It contains one active ingredient: Lisdexamfetamine dimesylate (60 mg per dose). This is a 'prodrug,' meaning it is biologically inactive when swallowed and is converted by enzymes in the blood into its active form, dextroamphetamine, which helps increase levels of dopamine and norepinephrine in the brain. Vyvanse is a controlled substance with a potential for abuse and dependence. It is not a source of dietary nutrients. Common side effects may include insomnia, decreased appetite, dry mouth, and increased heart rate. This information is for educational purposes and does not constitute medical advice; always consult your healthcare provider regarding medication use.\",\"gramWeight\":0.06,\"hiddenFromFriends\":true,\"id\":\"009E88AD-30B0-4FA3-AE4A-ED5AF7FDFE0A\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"60 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":60,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-13T07:51:35.179Z\",\"useCount\":0}",
      "consumed_timestamp": "",
      "timestamp_source": "recorded_timestamp"
    },
    {
      "day": "2026-07-14",
      "recorded_timestamp": "2026-07-14T08:53:54.908Z",
      "local_time": "3:53 AM",
      "meal_id": "F7A839F4-4A8A-43FE-9198-135C16E6D5E1",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 60,
      "recorded_unit": "mg",
      "meal_name": "Daily Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":60,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"createdAt\":\"2026-07-14T08:53:54.908Z\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system (CNS) stimulant used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. It contains one active ingredient: Lisdexamfetamine dimesylate (60 mg per dose). This is a 'prodrug,' meaning it is biologically inactive when swallowed and is converted by enzymes in the blood into its active form, dextroamphetamine, which helps increase levels of dopamine and norepinephrine in the brain. Vyvanse is a controlled substance with a potential for abuse and dependence. It is not a source of dietary nutrients. Common side effects may include insomnia, decreased appetite, dry mouth, and increased heart rate. This information is for educational purposes and does not constitute medical advice; always consult your healthcare provider regarding medication use.\",\"gramWeight\":0.06,\"hiddenFromFriends\":true,\"id\":\"F36E3BDD-617C-4DAB-A57C-CF867713C183\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"60 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":60,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-14T08:53:54.908Z\",\"useCount\":0}",
      "consumed_timestamp": "",
      "timestamp_source": "recorded_timestamp"
    },
    {
      "day": "2026-07-15",
      "recorded_timestamp": "2026-07-15T11:35:07.082Z",
      "local_time": "6:35 AM",
      "meal_id": "8AB21445-92CD-4034-A962-2C05B40FB996",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 60,
      "recorded_unit": "mg",
      "meal_name": "Daily Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":60,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"createdAt\":\"2026-07-15T11:35:07.082Z\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system (CNS) stimulant used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. It contains one active ingredient: Lisdexamfetamine dimesylate (60 mg per dose). This is a 'prodrug,' meaning it is biologically inactive when swallowed and is converted by enzymes in the blood into its active form, dextroamphetamine, which helps increase levels of dopamine and norepinephrine in the brain. Vyvanse is a controlled substance with a potential for abuse and dependence. It is not a source of dietary nutrients. Common side effects may include insomnia, decreased appetite, dry mouth, and increased heart rate. This information is for educational purposes and does not constitute medical advice; always consult your healthcare provider regarding medication use.\",\"gramWeight\":0.06,\"hiddenFromFriends\":true,\"id\":\"2197F8B9-2FA5-4C56-BD9D-4DAF6B0661C6\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"60 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":60,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-15T11:35:07.082Z\",\"useCount\":0}",
      "consumed_timestamp": "",
      "timestamp_source": "recorded_timestamp"
    },
    {
      "day": "2026-07-16",
      "recorded_timestamp": "2026-07-17T04:57:26.845Z",
      "local_time": "8:52 AM",
      "meal_id": "3467B4C0-860E-4FF2-AA42-A089A0002FF1",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 20,
      "recorded_unit": "mg",
      "meal_name": "Supplements",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":20,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-07-16T13:52:26.000Z\",\"createdAt\":\"2026-07-17T04:57:15.448Z\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. It is a prodrug, meaning it is pharmacologically inactive until it is metabolized in the body into its active form, dextroamphetamine. This medication contains no nutritional value (calories, vitamins, or minerals). Safety note: Vyvanse has a high potential for abuse and dependence. It should only be taken as prescribed by a healthcare provider. Do not combine with other stimulants or medications without medical supervision. Common side effects may include decreased appetite, insomnia, and dry mouth. This information is for educational purposes and does not constitute medical advice.\",\"gramWeight\":0.02,\"hiddenFromFriends\":true,\"id\":\"2F294A44-9C82-4118-A6CE-C2264783788B\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"20 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":20,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-17T04:57:50.606Z\",\"useCount\":0}",
      "consumed_timestamp": "2026-07-16T13:52:26.000Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-07-16",
      "recorded_timestamp": "2026-07-17T04:57:58.702Z",
      "local_time": "12:24 PM",
      "meal_id": "B544103C-50DC-49CD-B703-35A2BB6D1681",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 20,
      "recorded_unit": "mg",
      "meal_name": "Supplements",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":20,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-07-16T17:24:58.000Z\",\"createdAt\":\"2026-07-17T04:57:15.448Z\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. It is a prodrug, meaning it is pharmacologically inactive until it is metabolized in the body into its active form, dextroamphetamine. This medication contains no nutritional value (calories, vitamins, or minerals). Safety note: Vyvanse has a high potential for abuse and dependence. It should only be taken as prescribed by a healthcare provider. Do not combine with other stimulants or medications without medical supervision. Common side effects may include decreased appetite, insomnia, and dry mouth. This information is for educational purposes and does not constitute medical advice.\",\"gramWeight\":0.02,\"hiddenFromFriends\":true,\"id\":\"BE1D1DE6-EC2F-4053-BB95-E5198079F1BB\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"lastUsed\":\"2026-07-17T04:57:57.723Z\",\"name\":\"Vyvanse\",\"notes\":\"20 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":20,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-17T04:58:11.512Z\",\"useCount\":2}",
      "consumed_timestamp": "2026-07-16T17:24:58.000Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-07-17",
      "recorded_timestamp": "2026-07-17T17:41:48.215Z",
      "local_time": "12:41 PM",
      "meal_id": "AFE2943D-8DEC-46FA-95EF-240668EA3F2C",
      "item_index": 0,
      "item_name": "Vyvanse (lisdexamfetamine dimesylate)",
      "recorded_dose_mg": 20,
      "recorded_unit": "mg",
      "meal_name": "Supplements",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":20,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"createdAt\":\"2026-07-17T17:41:48.215Z\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. The active ingredient is lisdexamfetamine dimesylate (20 mg per dose), which acts as a prodrug; it is pharmacologically inactive until it is metabolized in the body into dextroamphetamine, which then increases levels of norepinephrine and dopamine in the brain. This medication is a Schedule II controlled substance due to its potential for misuse, abuse, and dependence. It is not a source of nutrients. Safety note: Do not combine with other stimulants or medications that alter urinary pH (like high doses of Vitamin C/ascorbic acid) without consulting a doctor, as these can affect medication absorption and efficacy. Always follow your healthcare provider's specific dosing instructions.\",\"gramWeight\":0.02,\"hiddenFromFriends\":true,\"id\":\"AFB08252-4545-4284-8910-BF232E27EB65\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse (lisdexamfetamine dimesylate)\",\"notes\":\"20 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":20,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-17T17:41:48.215Z\",\"useCount\":0}",
      "consumed_timestamp": "",
      "timestamp_source": "recorded_timestamp"
    },
    {
      "day": "2026-07-18",
      "recorded_timestamp": "2026-07-18T14:19:52.355Z",
      "local_time": "9:19 AM",
      "meal_id": "775698A1-1F2C-4078-9983-27C7437FF1E4",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 20,
      "recorded_unit": "mg",
      "meal_name": "Supplements",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":20,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"createdAt\":\"2026-07-17T04:57:15.448Z\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. It is a prodrug, meaning it is pharmacologically inactive until it is metabolized in the body into its active form, dextroamphetamine. This medication contains no nutritional value (calories, vitamins, or minerals). Safety note: Vyvanse has a high potential for abuse and dependence. It should only be taken as prescribed by a healthcare provider. Do not combine with other stimulants or medications without medical supervision. Common side effects may include decreased appetite, insomnia, and dry mouth. This information is for educational purposes and does not constitute medical advice.\",\"gramWeight\":0.02,\"hiddenFromFriends\":true,\"id\":\"77AC151D-195D-4415-8ABC-55CD99CDA001\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"lastUsed\":\"2026-07-18T14:19:51.046Z\",\"name\":\"Vyvanse\",\"notes\":\"20 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":20,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-17T04:57:15.448Z\",\"useCount\":5}",
      "consumed_timestamp": "",
      "timestamp_source": "recorded_timestamp"
    },
    {
      "day": "2026-07-18",
      "recorded_timestamp": "2026-07-18T17:50:50.817Z",
      "local_time": "12:50 PM",
      "meal_id": "A22675AB-4956-4176-8853-E0918BC90C14",
      "item_index": 0,
      "item_name": "Vyvanse (lisdexamfetamine dimesylate)",
      "recorded_dose_mg": 20,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":20,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-07-18T17:50:50.817Z\",\"createdAt\":\"2026-07-18T17:50:53.002Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. The active ingredient is lisdexamfetamine dimesylate (20 mg per dose), which acts as a prodrug; it is pharmacologically inactive until it is metabolized in the body into dextroamphetamine, which then increases levels of norepinephrine and dopamine in the brain. This medication is a Schedule II controlled substance due to its potential for misuse, abuse, and dependence. It is not a source of nutrients. Safety note: Do not combine with other stimulants or medications that alter urinary pH (like high doses of Vitamin C/ascorbic acid) without consulting a doctor, as these can affect medication absorption and efficacy. Always follow your healthcare provider's specific dosing instructions.\",\"gramWeight\":0.02,\"hiddenFromFriends\":true,\"id\":\"621DD8CA-6857-424E-A924-F5951492E9D1\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"lastUsed\":\"2026-07-18T14:19:12.472Z\",\"name\":\"Vyvanse (lisdexamfetamine dimesylate)\",\"notes\":\"20 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":20,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-18T17:50:53.002Z\",\"useCount\":1}",
      "consumed_timestamp": "2026-07-18T17:50:50.817Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-07-19",
      "recorded_timestamp": "2026-07-19T17:20:20.980Z",
      "local_time": "12:20 PM",
      "meal_id": "D59E2A04-9991-442A-945D-B1A9E58B78E2",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 20,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":20,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-07-19T17:20:20.980Z\",\"createdAt\":\"2026-07-19T17:20:20.980Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. It is a prodrug, meaning it is pharmacologically inactive until it is metabolized in the body into its active form, dextroamphetamine. This medication contains no nutritional value (calories, vitamins, or minerals). Safety note: Vyvanse has a high potential for abuse and dependence. It should only be taken as prescribed by a healthcare provider. Do not combine with other stimulants or medications without medical supervision. Common side effects may include decreased appetite, insomnia, and dry mouth. This information is for educational purposes and does not constitute medical advice.\",\"gramWeight\":0.02,\"hiddenFromFriends\":true,\"id\":\"7166F289-270C-4211-A7FE-D5CC8A4D0C29\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"lastUsed\":\"2026-07-18T14:19:16.490Z\",\"name\":\"Vyvanse\",\"notes\":\"20 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":20,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-19T17:20:20.980Z\",\"useCount\":4}",
      "consumed_timestamp": "2026-07-19T17:20:20.980Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-07-19",
      "recorded_timestamp": "2026-07-19T17:20:21.782Z",
      "local_time": "12:20 PM",
      "meal_id": "A46254C0-55C5-42AE-B4BF-77AA1C5D9D84",
      "item_index": 0,
      "item_name": "Vyvanse (lisdexamfetamine dimesylate)",
      "recorded_dose_mg": 20,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":20,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-07-19T17:20:21.782Z\",\"createdAt\":\"2026-07-19T17:20:21.782Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. The active ingredient is lisdexamfetamine dimesylate (20 mg per dose), which acts as a prodrug; it is pharmacologically inactive until it is metabolized in the body into dextroamphetamine, which then increases levels of norepinephrine and dopamine in the brain. This medication is a Schedule II controlled substance due to its potential for misuse, abuse, and dependence. It is not a source of nutrients. Safety note: Do not combine with other stimulants or medications that alter urinary pH (like high doses of Vitamin C/ascorbic acid) without consulting a doctor, as these can affect medication absorption and efficacy. Always follow your healthcare provider's specific dosing instructions.\",\"gramWeight\":0.02,\"hiddenFromFriends\":true,\"id\":\"AD538156-613D-4038-909D-293D5510741D\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"lastUsed\":\"2026-07-18T14:19:12.472Z\",\"name\":\"Vyvanse (lisdexamfetamine dimesylate)\",\"notes\":\"20 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":20,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-19T17:20:21.782Z\",\"useCount\":1}",
      "consumed_timestamp": "2026-07-19T17:20:21.782Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-07-20",
      "recorded_timestamp": "2026-07-20T14:30:59.180Z",
      "local_time": "6:55 AM",
      "meal_id": "3EE8F3B2-1C6D-424B-B962-D40B10A3948F",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 20,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":20,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-07-20T11:55:00.000Z\",\"createdAt\":\"2026-07-20T14:30:59.180Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. It is a prodrug, meaning it is pharmacologically inactive until it is metabolized in the body into its active form, dextroamphetamine. This medication contains no nutritional value (calories, vitamins, or minerals). Safety note: Vyvanse has a high potential for abuse and dependence. It should only be taken as prescribed by a healthcare provider. Do not combine with other stimulants or medications without medical supervision. Common side effects may include decreased appetite, insomnia, and dry mouth. This information is for educational purposes and does not constitute medical advice.\",\"gramWeight\":0.02,\"hiddenFromFriends\":true,\"id\":\"ABB3B3BE-F027-4E57-8C50-0EF70A9D9B3B\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"lastUsed\":\"2026-07-19T17:20:11.193Z\",\"name\":\"Vyvanse\",\"notes\":\"20 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":20,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-20T14:32:24.345Z\",\"useCount\":6}",
      "consumed_timestamp": "2026-07-20T11:55:00.000Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-07-20",
      "recorded_timestamp": "2026-07-20T18:23:20.818Z",
      "local_time": "1:23 PM",
      "meal_id": "91F904BB-7EFC-4CFC-B5E3-BA5E28FE0F2D",
      "item_index": 0,
      "item_name": "Vyvanse (lisdexamfetamine dimesylate)",
      "recorded_dose_mg": 20,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":20,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-07-20T18:23:20.818Z\",\"createdAt\":\"2026-07-20T18:23:20.818Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. The active ingredient is lisdexamfetamine dimesylate (20 mg per dose), which acts as a prodrug; it is pharmacologically inactive until it is metabolized in the body into dextroamphetamine, which then increases levels of norepinephrine and dopamine in the brain. This medication is a Schedule II controlled substance due to its potential for misuse, abuse, and dependence. It is not a source of nutrients. Safety note: Do not combine with other stimulants or medications that alter urinary pH (like high doses of Vitamin C/ascorbic acid) without consulting a doctor, as these can affect medication absorption and efficacy. Always follow your healthcare provider's specific dosing instructions.\",\"gramWeight\":0.02,\"hiddenFromFriends\":true,\"id\":\"293AB052-5C33-49DF-B818-92F2C6B1F82F\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"lastUsed\":\"2026-07-18T14:19:12.472Z\",\"name\":\"Vyvanse (lisdexamfetamine dimesylate)\",\"notes\":\"20 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":20,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-20T18:23:20.818Z\",\"useCount\":1}",
      "consumed_timestamp": "2026-07-20T18:23:20.818Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-07-21",
      "recorded_timestamp": "2026-07-21T15:55:26.023Z",
      "local_time": "10:55 AM",
      "meal_id": "3FD772AB-1349-4B79-91AA-419ED9D78877",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 20,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":20,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-07-21T15:55:26.023Z\",\"createdAt\":\"2026-07-21T15:55:26.023Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. It is a prodrug, meaning it is pharmacologically inactive until it is metabolized in the body into its active form, dextroamphetamine. This medication contains no nutritional value (calories, vitamins, or minerals). Safety note: Vyvanse has a high potential for abuse and dependence. It should only be taken as prescribed by a healthcare provider. Do not combine with other stimulants or medications without medical supervision. Common side effects may include decreased appetite, insomnia, and dry mouth. This information is for educational purposes and does not constitute medical advice.\",\"gramWeight\":0.02,\"hiddenFromFriends\":true,\"id\":\"96FE890B-9921-4369-AD07-721B94287FF1\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"lastUsed\":\"2026-07-19T17:20:11.193Z\",\"name\":\"Vyvanse\",\"notes\":\"20 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":20,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-21T15:55:26.023Z\",\"useCount\":6}",
      "consumed_timestamp": "2026-07-21T15:55:26.023Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-07-21",
      "recorded_timestamp": "2026-07-21T15:55:26.829Z",
      "local_time": "10:55 AM",
      "meal_id": "66CC0B84-5939-4F5A-A922-53A9B8DB5407",
      "item_index": 0,
      "item_name": "Vyvanse (lisdexamfetamine dimesylate)",
      "recorded_dose_mg": 20,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":20,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-07-21T15:55:26.829Z\",\"createdAt\":\"2026-07-21T15:55:26.829Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. The active ingredient is lisdexamfetamine dimesylate (20 mg per dose), which acts as a prodrug; it is pharmacologically inactive until it is metabolized in the body into dextroamphetamine, which then increases levels of norepinephrine and dopamine in the brain. This medication is a Schedule II controlled substance due to its potential for misuse, abuse, and dependence. It is not a source of nutrients. Safety note: Do not combine with other stimulants or medications that alter urinary pH (like high doses of Vitamin C/ascorbic acid) without consulting a doctor, as these can affect medication absorption and efficacy. Always follow your healthcare provider's specific dosing instructions.\",\"gramWeight\":0.02,\"hiddenFromFriends\":true,\"id\":\"4254F945-A1A4-4C82-9DEF-5644B8332587\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"lastUsed\":\"2026-07-18T14:19:12.472Z\",\"name\":\"Vyvanse (lisdexamfetamine dimesylate)\",\"notes\":\"20 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":20,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-21T15:55:26.829Z\",\"useCount\":1}",
      "consumed_timestamp": "2026-07-21T15:55:26.829Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-07-22",
      "recorded_timestamp": "2026-07-22T19:13:11.480Z",
      "local_time": "2:13 PM",
      "meal_id": "CE8392A9-479A-4D7C-977F-F7E8BDDDCD53",
      "item_index": 0,
      "item_name": "Vyvanse (lisdexamfetamine dimesylate)",
      "recorded_dose_mg": 20,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":20,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-07-22T19:13:11.480Z\",\"createdAt\":\"2026-07-22T19:13:11.480Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. The active ingredient is lisdexamfetamine dimesylate (20 mg per dose), which acts as a prodrug; it is pharmacologically inactive until it is metabolized in the body into dextroamphetamine, which then increases levels of norepinephrine and dopamine in the brain. This medication is a Schedule II controlled substance due to its potential for misuse, abuse, and dependence. It is not a source of nutrients. Safety note: Do not combine with other stimulants or medications that alter urinary pH (like high doses of Vitamin C/ascorbic acid) without consulting a doctor, as these can affect medication absorption and efficacy. Always follow your healthcare provider's specific dosing instructions.\",\"gramWeight\":0.02,\"hiddenFromFriends\":true,\"id\":\"C0F79882-0C62-4114-8832-CD72A7AC2962\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"lastUsed\":\"2026-07-18T14:19:12.472Z\",\"name\":\"Vyvanse (lisdexamfetamine dimesylate)\",\"notes\":\"20 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":20,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-22T19:13:11.480Z\",\"useCount\":1}",
      "consumed_timestamp": "2026-07-22T19:13:11.480Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-07-22",
      "recorded_timestamp": "2026-07-22T19:13:16.511Z",
      "local_time": "2:13 PM",
      "meal_id": "B5F3ADE3-1DAD-43F2-9F59-6AEEA080B74E",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 20,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":20,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-07-22T19:13:16.511Z\",\"createdAt\":\"2026-07-22T19:13:16.511Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. It is a prodrug, meaning it is pharmacologically inactive until it is metabolized in the body into its active form, dextroamphetamine. This medication contains no nutritional value (calories, vitamins, or minerals). Safety note: Vyvanse has a high potential for abuse and dependence. It should only be taken as prescribed by a healthcare provider. Do not combine with other stimulants or medications without medical supervision. Common side effects may include decreased appetite, insomnia, and dry mouth. This information is for educational purposes and does not constitute medical advice.\",\"gramWeight\":0.02,\"hiddenFromFriends\":true,\"id\":\"096E68AD-0D20-440A-AA14-5B6C0CC7D28E\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"lastUsed\":\"2026-07-19T17:20:11.193Z\",\"name\":\"Vyvanse\",\"notes\":\"20 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":20,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-22T19:13:16.511Z\",\"useCount\":6}",
      "consumed_timestamp": "2026-07-22T19:13:16.511Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-07-23",
      "recorded_timestamp": "2026-07-23T20:05:31.904Z",
      "local_time": "7:57 AM",
      "meal_id": "28CABFEA-A71B-49A5-84AE-3651AAEDB380",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 20,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":20,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-07-23T12:57:31.000Z\",\"createdAt\":\"2026-07-23T20:05:31.904Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. It is a prodrug, meaning it is pharmacologically inactive until it is metabolized in the body into its active form, dextroamphetamine. This medication contains no nutritional value (calories, vitamins, or minerals). Safety note: Vyvanse has a high potential for abuse and dependence. It should only be taken as prescribed by a healthcare provider. Do not combine with other stimulants or medications without medical supervision. Common side effects may include decreased appetite, insomnia, and dry mouth. This information is for educational purposes and does not constitute medical advice.\",\"gramWeight\":0.02,\"hiddenFromFriends\":true,\"id\":\"76066E72-AD5D-49B6-A056-F4B8D1FA877C\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"lastUsed\":\"2026-07-19T17:20:11.193Z\",\"name\":\"Vyvanse\",\"notes\":\"20 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":20,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-23T20:06:17.703Z\",\"useCount\":6}",
      "consumed_timestamp": "2026-07-23T12:57:31.000Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-07-23",
      "recorded_timestamp": "2026-07-23T20:05:34.562Z",
      "local_time": "7:57 AM",
      "meal_id": "4FDD8824-E5A9-4360-8350-1D4EA1BE9F53",
      "item_index": 0,
      "item_name": "Vyvanse (lisdexamfetamine dimesylate)",
      "recorded_dose_mg": 20,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":20,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-07-23T12:57:34.000Z\",\"createdAt\":\"2026-07-23T20:05:34.562Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. The active ingredient is lisdexamfetamine dimesylate (20 mg per dose), which acts as a prodrug; it is pharmacologically inactive until it is metabolized in the body into dextroamphetamine, which then increases levels of norepinephrine and dopamine in the brain. This medication is a Schedule II controlled substance due to its potential for misuse, abuse, and dependence. It is not a source of nutrients. Safety note: Do not combine with other stimulants or medications that alter urinary pH (like high doses of Vitamin C/ascorbic acid) without consulting a doctor, as these can affect medication absorption and efficacy. Always follow your healthcare provider's specific dosing instructions.\",\"gramWeight\":0.02,\"hiddenFromFriends\":true,\"id\":\"B0CE76BE-8974-4432-B28C-08A08CD3DE26\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"lastUsed\":\"2026-07-18T14:19:12.472Z\",\"name\":\"Vyvanse (lisdexamfetamine dimesylate)\",\"notes\":\"20 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":20,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-23T20:06:10.847Z\",\"useCount\":1}",
      "consumed_timestamp": "2026-07-23T12:57:34.000Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-07-25",
      "recorded_timestamp": "2026-07-26T04:49:50.568Z",
      "local_time": "10:32 AM",
      "meal_id": "E47DC9B6-C76C-42CC-9AFE-7B75AE96D09A",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 20,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":20,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-07-25T15:32:50.000Z\",\"createdAt\":\"2026-07-26T04:49:50.568Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. It is a prodrug, meaning it is pharmacologically inactive until it is metabolized in the body into its active form, dextroamphetamine. This medication contains no nutritional value (calories, vitamins, or minerals). Safety note: Vyvanse has a high potential for abuse and dependence. It should only be taken as prescribed by a healthcare provider. Do not combine with other stimulants or medications without medical supervision. Common side effects may include decreased appetite, insomnia, and dry mouth. This information is for educational purposes and does not constitute medical advice.\",\"gramWeight\":0.02,\"hiddenFromFriends\":true,\"id\":\"22643496-6FF9-41E2-9BE3-D84146FE63B9\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"lastUsed\":\"2026-07-19T17:20:11.193Z\",\"name\":\"Vyvanse\",\"notes\":\"20 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":20,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-26T04:50:06.656Z\",\"useCount\":6}",
      "consumed_timestamp": "2026-07-25T15:32:50.000Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-07-25",
      "recorded_timestamp": "2026-07-26T04:50:02.319Z",
      "local_time": "10:33 AM",
      "meal_id": "E5DF69F1-9743-4F44-BA71-4851BDB611D6",
      "item_index": 0,
      "item_name": "Vyvanse (lisdexamfetamine dimesylate)",
      "recorded_dose_mg": 20,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":20,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-07-25T15:33:02.000Z\",\"createdAt\":\"2026-07-26T04:50:02.319Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. The active ingredient is lisdexamfetamine dimesylate (20 mg per dose), which acts as a prodrug; it is pharmacologically inactive until it is metabolized in the body into dextroamphetamine, which then increases levels of norepinephrine and dopamine in the brain. This medication is a Schedule II controlled substance due to its potential for misuse, abuse, and dependence. It is not a source of nutrients. Safety note: Do not combine with other stimulants or medications that alter urinary pH (like high doses of Vitamin C/ascorbic acid) without consulting a doctor, as these can affect medication absorption and efficacy. Always follow your healthcare provider's specific dosing instructions.\",\"gramWeight\":0.02,\"hiddenFromFriends\":true,\"id\":\"3993B0E7-F354-4AF9-AFF5-3434C1BBA7EA\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"lastUsed\":\"2026-07-18T14:19:12.472Z\",\"name\":\"Vyvanse (lisdexamfetamine dimesylate)\",\"notes\":\"20 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":20,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-26T04:50:12.469Z\",\"useCount\":1}",
      "consumed_timestamp": "2026-07-25T15:33:02.000Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-07-26",
      "recorded_timestamp": "2026-07-26T22:11:40.106Z",
      "local_time": "5:11 PM",
      "meal_id": "374B2EFE-8BF0-4156-BB8C-844FC7FAB99F",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 20,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":20,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-07-26T22:11:40.106Z\",\"createdAt\":\"2026-07-26T22:11:40.106Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. It is a prodrug, meaning it is pharmacologically inactive until it is metabolized in the body into its active form, dextroamphetamine. This medication contains no nutritional value (calories, vitamins, or minerals). Safety note: Vyvanse has a high potential for abuse and dependence. It should only be taken as prescribed by a healthcare provider. Do not combine with other stimulants or medications without medical supervision. Common side effects may include decreased appetite, insomnia, and dry mouth. This information is for educational purposes and does not constitute medical advice.\",\"gramWeight\":0.02,\"hiddenFromFriends\":true,\"id\":\"0D0B8ACE-8D8F-4CD0-AD00-50FEFBBF003A\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"lastUsed\":\"2026-07-18T14:19:16.490Z\",\"name\":\"Vyvanse\",\"notes\":\"20 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":20,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-26T22:11:40.106Z\",\"useCount\":4}",
      "consumed_timestamp": "2026-07-26T22:11:40.106Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-07-27",
      "recorded_timestamp": "2026-07-27T17:36:28.402Z",
      "local_time": "10:36 AM",
      "meal_id": "13CB4ECC-2B81-4BD6-AD41-60B9D95779C4",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 20,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":20,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-07-27T15:36:28.000Z\",\"createdAt\":\"2026-07-27T17:36:28.402Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. It is a prodrug, meaning it is pharmacologically inactive until it is metabolized in the body into its active form, dextroamphetamine. This medication contains no nutritional value (calories, vitamins, or minerals). Safety note: Vyvanse has a high potential for abuse and dependence. It should only be taken as prescribed by a healthcare provider. Do not combine with other stimulants or medications without medical supervision. Common side effects may include decreased appetite, insomnia, and dry mouth. This information is for educational purposes and does not constitute medical advice.\",\"gramWeight\":0.02,\"hiddenFromFriends\":true,\"id\":\"84D06C02-994C-4038-8512-CB7CE4F8AC1A\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"lastUsed\":\"2026-07-19T17:20:11.193Z\",\"name\":\"Vyvanse\",\"notes\":\"20 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":20,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-27T17:36:39.757Z\",\"useCount\":6}",
      "consumed_timestamp": "2026-07-27T15:36:28.000Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-07-27",
      "recorded_timestamp": "2026-07-27T17:36:30.032Z",
      "local_time": "10:36 AM",
      "meal_id": "3A13C9AB-1DA0-4B9D-9988-36E28BC80889",
      "item_index": 0,
      "item_name": "Vyvanse (lisdexamfetamine dimesylate)",
      "recorded_dose_mg": 20,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":20,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-07-27T15:36:30.000Z\",\"createdAt\":\"2026-07-27T17:36:30.032Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. The active ingredient is lisdexamfetamine dimesylate (20 mg per dose), which acts as a prodrug; it is pharmacologically inactive until it is metabolized in the body into dextroamphetamine, which then increases levels of norepinephrine and dopamine in the brain. This medication is a Schedule II controlled substance due to its potential for misuse, abuse, and dependence. It is not a source of nutrients. Safety note: Do not combine with other stimulants or medications that alter urinary pH (like high doses of Vitamin C/ascorbic acid) without consulting a doctor, as these can affect medication absorption and efficacy. Always follow your healthcare provider's specific dosing instructions.\",\"gramWeight\":0.02,\"hiddenFromFriends\":true,\"id\":\"A7753B47-EEDE-4AA5-ABEC-A46E80C36AF9\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"lastUsed\":\"2026-07-18T14:19:12.472Z\",\"name\":\"Vyvanse (lisdexamfetamine dimesylate)\",\"notes\":\"20 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":20,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-27T17:36:35.780Z\",\"useCount\":1}",
      "consumed_timestamp": "2026-07-27T15:36:30.000Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-07-28",
      "recorded_timestamp": "2026-07-28T15:32:08.578Z",
      "local_time": "10:32 AM",
      "meal_id": "CDC49F3A-2826-4AD6-80A6-B1257A422F33",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 20,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":20,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-07-28T15:32:08.578Z\",\"createdAt\":\"2026-07-28T15:32:08.578Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. It is a prodrug, meaning it is pharmacologically inactive until it is metabolized in the body into its active form, dextroamphetamine. This medication contains no nutritional value (calories, vitamins, or minerals). Safety note: Vyvanse has a high potential for abuse and dependence. It should only be taken as prescribed by a healthcare provider. Do not combine with other stimulants or medications without medical supervision. Common side effects may include decreased appetite, insomnia, and dry mouth. This information is for educational purposes and does not constitute medical advice.\",\"gramWeight\":0.02,\"hiddenFromFriends\":true,\"id\":\"4CFF5300-67A7-48CF-A434-4586FFD4CAD0\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"lastUsed\":\"2026-07-19T17:20:11.193Z\",\"name\":\"Vyvanse\",\"notes\":\"20 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":20,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-28T15:32:08.578Z\",\"useCount\":6}",
      "consumed_timestamp": "2026-07-28T15:32:08.578Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-07-28",
      "recorded_timestamp": "2026-07-28T15:32:09.504Z",
      "local_time": "10:32 AM",
      "meal_id": "117F1690-F275-47A6-A9B7-1364561C48F8",
      "item_index": 0,
      "item_name": "Vyvanse (lisdexamfetamine dimesylate)",
      "recorded_dose_mg": 20,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":20,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-07-28T15:32:09.504Z\",\"createdAt\":\"2026-07-28T15:32:09.504Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. The active ingredient is lisdexamfetamine dimesylate (20 mg per dose), which acts as a prodrug; it is pharmacologically inactive until it is metabolized in the body into dextroamphetamine, which then increases levels of norepinephrine and dopamine in the brain. This medication is a Schedule II controlled substance due to its potential for misuse, abuse, and dependence. It is not a source of nutrients. Safety note: Do not combine with other stimulants or medications that alter urinary pH (like high doses of Vitamin C/ascorbic acid) without consulting a doctor, as these can affect medication absorption and efficacy. Always follow your healthcare provider's specific dosing instructions.\",\"gramWeight\":0.02,\"hiddenFromFriends\":true,\"id\":\"448201F4-0BF0-412E-8813-8D9B42F3615D\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"lastUsed\":\"2026-07-18T14:19:12.472Z\",\"name\":\"Vyvanse (lisdexamfetamine dimesylate)\",\"notes\":\"20 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":20,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-28T15:32:09.504Z\",\"useCount\":1}",
      "consumed_timestamp": "2026-07-28T15:32:09.504Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-07-30",
      "recorded_timestamp": "2026-07-30T18:50:06.270Z",
      "local_time": "1:50 PM",
      "meal_id": "CAE5AF56-FB47-4911-B36E-24788EA749F4",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 20,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":20,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-07-30T18:50:06.270Z\",\"createdAt\":\"2026-07-30T18:50:06.270Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. It is a prodrug, meaning it is pharmacologically inactive until it is metabolized in the body into its active form, dextroamphetamine. This medication contains no nutritional value (calories, vitamins, or minerals). Safety note: Vyvanse has a high potential for abuse and dependence. It should only be taken as prescribed by a healthcare provider. Do not combine with other stimulants or medications without medical supervision. Common side effects may include decreased appetite, insomnia, and dry mouth. This information is for educational purposes and does not constitute medical advice.\",\"gramWeight\":0.02,\"hiddenFromFriends\":true,\"id\":\"3FA1F2CF-E3F8-4FFC-A0BA-4A3D651A063B\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"lastUsed\":\"2026-07-19T17:20:11.193Z\",\"name\":\"Vyvanse\",\"notes\":\"20 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":20,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-30T18:50:06.270Z\",\"useCount\":6}",
      "consumed_timestamp": "2026-07-30T18:50:06.270Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-07-30",
      "recorded_timestamp": "2026-07-30T18:50:08.881Z",
      "local_time": "1:50 PM",
      "meal_id": "DAC7CAA0-F19D-4257-8147-0CDB4FEBFF2D",
      "item_index": 0,
      "item_name": "Vyvanse (lisdexamfetamine dimesylate)",
      "recorded_dose_mg": 20,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":20,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-07-30T18:50:08.881Z\",\"createdAt\":\"2026-07-30T18:50:08.881Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. The active ingredient is lisdexamfetamine dimesylate (20 mg per dose), which acts as a prodrug; it is pharmacologically inactive until it is metabolized in the body into dextroamphetamine, which then increases levels of norepinephrine and dopamine in the brain. This medication is a Schedule II controlled substance due to its potential for misuse, abuse, and dependence. It is not a source of nutrients. Safety note: Do not combine with other stimulants or medications that alter urinary pH (like high doses of Vitamin C/ascorbic acid) without consulting a doctor, as these can affect medication absorption and efficacy. Always follow your healthcare provider's specific dosing instructions.\",\"gramWeight\":0.02,\"hiddenFromFriends\":true,\"id\":\"F5621AC4-04E9-45A9-B3CD-9589DF602D9E\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"lastUsed\":\"2026-07-18T14:19:12.472Z\",\"name\":\"Vyvanse (lisdexamfetamine dimesylate)\",\"notes\":\"20 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":20,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-30T18:50:08.881Z\",\"useCount\":1}",
      "consumed_timestamp": "2026-07-30T18:50:08.881Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-07-31",
      "recorded_timestamp": "2026-07-31T19:53:53.278Z",
      "local_time": "7:40 AM",
      "meal_id": "3CBAD8EC-4A51-4F16-93FE-7804FD10144C",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 20,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":20,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-07-31T12:40:53.000Z\",\"createdAt\":\"2026-07-31T19:53:53.278Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. It is a prodrug, meaning it is pharmacologically inactive until it is metabolized in the body into its active form, dextroamphetamine. This medication contains no nutritional value (calories, vitamins, or minerals). Safety note: Vyvanse has a high potential for abuse and dependence. It should only be taken as prescribed by a healthcare provider. Do not combine with other stimulants or medications without medical supervision. Common side effects may include decreased appetite, insomnia, and dry mouth. This information is for educational purposes and does not constitute medical advice.\",\"gramWeight\":0.02,\"hiddenFromFriends\":true,\"id\":\"C1C5F41F-CC8B-412A-82EA-02B73876C1CF\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"lastUsed\":\"2026-07-19T17:20:11.193Z\",\"name\":\"Vyvanse\",\"notes\":\"20 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":20,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-31T19:54:24.869Z\",\"useCount\":6}",
      "consumed_timestamp": "2026-07-31T12:40:53.000Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-07-31",
      "recorded_timestamp": "2026-07-31T19:53:54.605Z",
      "local_time": "7:45 AM",
      "meal_id": "E27700DA-1D70-4CF6-9B68-909B2C0F5C13",
      "item_index": 0,
      "item_name": "Vyvanse (lisdexamfetamine dimesylate)",
      "recorded_dose_mg": 20,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":20,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-07-31T12:45:54.000Z\",\"createdAt\":\"2026-07-31T19:53:54.605Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. The active ingredient is lisdexamfetamine dimesylate (20 mg per dose), which acts as a prodrug; it is pharmacologically inactive until it is metabolized in the body into dextroamphetamine, which then increases levels of norepinephrine and dopamine in the brain. This medication is a Schedule II controlled substance due to its potential for misuse, abuse, and dependence. It is not a source of nutrients. Safety note: Do not combine with other stimulants or medications that alter urinary pH (like high doses of Vitamin C/ascorbic acid) without consulting a doctor, as these can affect medication absorption and efficacy. Always follow your healthcare provider's specific dosing instructions.\",\"gramWeight\":0.02,\"hiddenFromFriends\":true,\"id\":\"90B4920B-4883-4C05-B200-904A126FF066\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"lastUsed\":\"2026-07-18T14:19:12.472Z\",\"name\":\"Vyvanse (lisdexamfetamine dimesylate)\",\"notes\":\"20 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":20,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-07-31T19:54:14.090Z\",\"useCount\":1}",
      "consumed_timestamp": "2026-07-31T12:45:54.000Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-08-01",
      "recorded_timestamp": "2026-08-01T14:39:47.353Z",
      "local_time": "9:39 AM",
      "meal_id": "3970D500-8F8A-4BAA-8B7D-4E5B42E47BBA",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 20,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":20,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-08-01T14:39:47.353Z\",\"createdAt\":\"2026-08-01T14:39:47.353Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. It is a prodrug, meaning it is pharmacologically inactive until it is metabolized in the body into its active form, dextroamphetamine. This medication contains no nutritional value (calories, vitamins, or minerals). Safety note: Vyvanse has a high potential for abuse and dependence. It should only be taken as prescribed by a healthcare provider. Do not combine with other stimulants or medications without medical supervision. Common side effects may include decreased appetite, insomnia, and dry mouth. This information is for educational purposes and does not constitute medical advice.\",\"gramWeight\":0.02,\"hiddenFromFriends\":true,\"id\":\"C1730DD8-884B-4B36-8C43-73004CC90DF0\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"lastUsed\":\"2026-07-19T17:20:11.193Z\",\"name\":\"Vyvanse\",\"notes\":\"20 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":20,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-08-01T14:39:47.353Z\",\"useCount\":6}",
      "consumed_timestamp": "2026-08-01T14:39:47.353Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-08-01",
      "recorded_timestamp": "2026-08-01T14:39:48.675Z",
      "local_time": "9:39 AM",
      "meal_id": "EB07C6A7-5839-4F5C-939D-3BE159EE12BD",
      "item_index": 0,
      "item_name": "Vyvanse (lisdexamfetamine dimesylate)",
      "recorded_dose_mg": 20,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":20,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-08-01T14:39:48.675Z\",\"createdAt\":\"2026-08-01T14:39:48.675Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. The active ingredient is lisdexamfetamine dimesylate (20 mg per dose), which acts as a prodrug; it is pharmacologically inactive until it is metabolized in the body into dextroamphetamine, which then increases levels of norepinephrine and dopamine in the brain. This medication is a Schedule II controlled substance due to its potential for misuse, abuse, and dependence. It is not a source of nutrients. Safety note: Do not combine with other stimulants or medications that alter urinary pH (like high doses of Vitamin C/ascorbic acid) without consulting a doctor, as these can affect medication absorption and efficacy. Always follow your healthcare provider's specific dosing instructions.\",\"gramWeight\":0.02,\"hiddenFromFriends\":true,\"id\":\"1153B2B4-A6FC-4B1B-8C13-412F74ABBDE8\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"lastUsed\":\"2026-07-18T14:19:12.472Z\",\"name\":\"Vyvanse (lisdexamfetamine dimesylate)\",\"notes\":\"20 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":20,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-08-01T14:39:48.675Z\",\"useCount\":1}",
      "consumed_timestamp": "2026-08-01T14:39:48.675Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-08-02",
      "recorded_timestamp": "2026-08-02T19:34:19.561Z",
      "local_time": "6:34 AM",
      "meal_id": "C36022FF-4F30-4DA2-8F50-286AD38B2570",
      "item_index": 0,
      "item_name": "Vyvanse (lisdexamfetamine dimesylate)",
      "recorded_dose_mg": 20,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":20,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-08-02T11:34:19.000Z\",\"createdAt\":\"2026-08-02T19:34:19.561Z\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. The active ingredient is lisdexamfetamine dimesylate (20 mg per dose), which acts as a prodrug; it is pharmacologically inactive until it is metabolized in the body into dextroamphetamine, which then increases levels of norepinephrine and dopamine in the brain. This medication is a Schedule II controlled substance due to its potential for misuse, abuse, and dependence. It is not a source of nutrients. Safety note: Do not combine with other stimulants or medications that alter urinary pH (like high doses of Vitamin C/ascorbic acid) without consulting a doctor, as these can affect medication absorption and efficacy. Always follow your healthcare provider's specific dosing instructions.\",\"gramWeight\":0.02,\"hiddenFromFriends\":true,\"id\":\"20C253CA-1A15-4F76-BA13-B433B7911A1C\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"lastUsed\":\"2026-08-02T19:34:11.588Z\",\"name\":\"Vyvanse (lisdexamfetamine dimesylate)\",\"notes\":\"20 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":20,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-08-02T19:35:49.721Z\",\"useCount\":15}",
      "consumed_timestamp": "2026-08-02T11:34:19.000Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-08-02",
      "recorded_timestamp": "2026-08-02T13:00:00.000Z",
      "local_time": "8:00 AM",
      "meal_id": "0FD64BE4-93E3-41DF-919F-9F2430853DD5",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 40,
      "recorded_unit": "mg",
      "meal_name": "Morning Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":40,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-08-02T13:00:00.000Z\",\"createdAt\":\"2026-08-02T19:35:12.216Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system stimulant used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. It is a prodrug, meaning it is inactive until metabolized by the body into its active form, dextroamphetamine. As a pharmaceutical medication, it contains no nutritional value (calories, vitamins, or minerals). Common side effects include decreased appetite, dry mouth, and insomnia. It is important to note that while the medication itself provides no nutrients, its appetite-suppressing effects can lead to reduced food intake; patients are often advised to maintain balanced nutrition and monitor their weight while under medical supervision. Always consult your healthcare provider regarding medication interactions, particularly with acidifying agents like Vitamin C (ascorbic acid), which can affect how the drug is processed.\",\"gramWeight\":0,\"hiddenFromFriends\":true,\"id\":\"ED7D402F-9B57-471B-90D2-F4495E814931\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"Active ingredient: 40 mg lisdexamfetamine dimesylate per capsule.\",\"nutrients\":{},\"productReference\":{\"activeComponents\":[{\"molecule\":{\"canonicalSMILES\":\"CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"inchiKey\":\"CETWSOHVEGTIBR-FORAGAHYSA-N\",\"isomericSMILES\":\"C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"iupacName\":\"(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide;methanesulfonic acid\",\"molecularFormula\":\"C17H33N3O7S2\",\"molecularWeight\":\"455.6\",\"pubChemCID\":11597697,\"title\":\"Lisdexamfetamine Dimesylate\"},\"name\":\"Lisdexamfetamine Dimesylate\",\"role\":\"Active ingredient\"}],\"brandName\":\"Vyvanse\",\"categoryLabel\":\"Human Prescription Drug\",\"confidence\":\"officialLabel\",\"displayName\":\"Vyvanse\",\"genericName\":\"Lisdexamfetamine Dimesylate\",\"lookedUpAt\":\"2026-08-02T19:34:50.124Z\",\"otherIngredients\":[\"artificial strawberry flavor\",\"colloidal silicon dioxide\",\"croscarmellose sodium\",\"guar gum\",\"magnesium stearate\",\"mannitol\",\"microcrystalline cellulose\",\"sucralose\"],\"query\":\"Vyvanse\",\"sources\":[{\"name\":\"FDA Structured Product Label\",\"url\":\"https://open.fda.gov/apis/drug/label/\"},{\"name\":\"NIH PubChem — Lisdexamfetamine Dimesylate\",\"url\":\"https://pubchem.ncbi.nlm.nih.gov/compound/11597697\"}],\"summary\":\"Vyvanse is an FDA-labeled product containing Lisdexamfetamine Dimesylate.\"},\"quantityWasUserAdjusted\":false,\"servingSize\":40,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-08-02T19:35:12.216Z\",\"useCount\":0}",
      "consumed_timestamp": "2026-08-02T13:00:00.000Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-08-03",
      "recorded_timestamp": "2026-08-03T15:54:30.181Z",
      "local_time": "10:54 AM",
      "meal_id": "21541ACC-60A5-4B47-9602-BB6197942B8B",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 20,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":20,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-08-03T15:54:30.181Z\",\"createdAt\":\"2026-08-03T15:54:30.181Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. It is a prodrug, meaning it is pharmacologically inactive until it is metabolized in the body into its active form, dextroamphetamine. This medication contains no nutritional value (calories, vitamins, or minerals). Safety note: Vyvanse has a high potential for abuse and dependence. It should only be taken as prescribed by a healthcare provider. Do not combine with other stimulants or medications without medical supervision. Common side effects may include decreased appetite, insomnia, and dry mouth. This information is for educational purposes and does not constitute medical advice.\",\"gramWeight\":0.02,\"hiddenFromFriends\":true,\"id\":\"7D95EA8B-3DEE-452C-A373-A82F6E38D2E8\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"lastUsed\":\"2026-08-01T14:41:35.058Z\",\"name\":\"Vyvanse\",\"notes\":\"20 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":20,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-08-03T15:54:30.181Z\",\"useCount\":21}",
      "consumed_timestamp": "2026-08-03T15:54:30.181Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-08-04",
      "recorded_timestamp": "2026-08-04T11:26:28.787Z",
      "local_time": "6:26 AM",
      "meal_id": "6F14EB9C-F7F5-4C0D-99BE-C780DD53433D",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 20,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":20,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-08-04T11:26:28.787Z\",\"createdAt\":\"2026-08-04T11:26:28.787Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. It is a prodrug, meaning it is pharmacologically inactive until it is metabolized in the body into its active form, dextroamphetamine. This medication contains no nutritional value (calories, vitamins, or minerals). Safety note: Vyvanse has a high potential for abuse and dependence. It should only be taken as prescribed by a healthcare provider. Do not combine with other stimulants or medications without medical supervision. Common side effects may include decreased appetite, insomnia, and dry mouth. This information is for educational purposes and does not constitute medical advice.\",\"gramWeight\":0.02,\"hiddenFromFriends\":true,\"id\":\"244A3833-C7A7-4CBB-88FB-0B8447F08129\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"lastUsed\":\"2026-08-01T14:41:35.058Z\",\"name\":\"Vyvanse\",\"notes\":\"20 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":20,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-08-04T11:26:28.787Z\",\"useCount\":21}",
      "consumed_timestamp": "2026-08-04T11:26:28.787Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-08-05",
      "recorded_timestamp": "2026-08-05T19:19:36.861Z",
      "local_time": "2:19 PM",
      "meal_id": "B7531FD4-633C-4AE4-8662-E8E8BBB23BEC",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 20,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":20,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-08-05T19:19:36.861Z\",\"createdAt\":\"2026-08-05T19:19:36.861Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate-to-severe binge eating disorder. It is a prodrug, meaning it is pharmacologically inactive until it is metabolized in the body into its active form, dextroamphetamine. This medication contains no nutritional value (calories, vitamins, or minerals). Safety note: Vyvanse has a high potential for abuse and dependence. It should only be taken as prescribed by a healthcare provider. Do not combine with other stimulants or medications without medical supervision. Common side effects may include decreased appetite, insomnia, and dry mouth. This information is for educational purposes and does not constitute medical advice.\",\"gramWeight\":0.02,\"hiddenFromFriends\":true,\"id\":\"4DAB8B7F-622E-476A-9117-70743E3088A7\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"lastUsed\":\"2026-08-01T14:41:35.058Z\",\"name\":\"Vyvanse\",\"notes\":\"20 mg lisdexamfetamine dimesylate per capsule\",\"nutrients\":{},\"quantityWasUserAdjusted\":false,\"servingSize\":20,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-08-05T19:19:36.861Z\",\"useCount\":21}",
      "consumed_timestamp": "2026-08-05T19:19:36.861Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-08-06",
      "recorded_timestamp": "2026-08-06T13:58:31.842Z",
      "local_time": "8:58 AM",
      "meal_id": "49640C70-74FA-420B-8045-D6E903B37C87",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 60,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":60,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-08-06T13:58:31.842Z\",\"createdAt\":\"2026-08-06T13:58:31.842Z\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system (CNS) stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate to severe binge eating disorder (BED). It is a prodrug, meaning it is inactive until metabolized by the body into its active form, dextroamphetamine. This medication contains no nutritional value. It carries a boxed warning for high potential for abuse, misuse, and addiction. Common side effects include decreased appetite, insomnia, dry mouth, and headache. Always follow your healthcare provider's instructions, as this is a controlled substance (Schedule II) and should not be shared or used without a prescription.\",\"gramWeight\":0.06,\"hiddenFromFriends\":true,\"id\":\"24651959-62D3-4271-ADF9-789E6A4E18BA\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"Active ingredient: Lisdexamfetamine dimesylate 60 mg per capsule. Inactive ingredients include microcrystalline cellulose, croscarmellose sodium, and magnesium stearate.\",\"nutrients\":{},\"productReference\":{\"activeComponents\":[{\"molecule\":{\"canonicalSMILES\":\"CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"inchiKey\":\"CETWSOHVEGTIBR-FORAGAHYSA-N\",\"isomericSMILES\":\"C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"iupacName\":\"(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide;methanesulfonic acid\",\"molecularFormula\":\"C17H33N3O7S2\",\"molecularWeight\":\"455.6\",\"pubChemCID\":11597697,\"title\":\"Lisdexamfetamine Dimesylate\"},\"name\":\"Lisdexamfetamine Dimesylate\",\"role\":\"Active ingredient\"}],\"brandName\":\"Vyvanse\",\"categoryLabel\":\"Human Prescription Drug\",\"confidence\":\"officialLabel\",\"displayName\":\"Vyvanse\",\"genericName\":\"Lisdexamfetamine Dimesylate\",\"lookedUpAt\":\"2026-08-06T13:57:53.255Z\",\"otherIngredients\":[\"artificial strawberry flavor\",\"colloidal silicon dioxide\",\"croscarmellose sodium\",\"guar gum\",\"magnesium stearate\",\"mannitol\",\"microcrystalline cellulose\",\"sucralose\"],\"query\":\"Vyvanse\",\"sources\":[{\"name\":\"FDA Structured Product Label\",\"url\":\"https://open.fda.gov/apis/drug/label/\"},{\"name\":\"NIH PubChem — Lisdexamfetamine Dimesylate\",\"url\":\"https://pubchem.ncbi.nlm.nih.gov/compound/11597697\"}],\"summary\":\"Vyvanse is an FDA-labeled product containing Lisdexamfetamine Dimesylate.\"},\"quantityWasUserAdjusted\":false,\"servingSize\":60,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-08-06T13:58:31.842Z\",\"useCount\":0}",
      "consumed_timestamp": "2026-08-06T13:58:31.842Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-08-08",
      "recorded_timestamp": "2026-08-08T17:00:32.102Z",
      "local_time": "12:00 PM",
      "meal_id": "282E09C8-C33F-4B49-9DC1-0ECFF6D4B925",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 60,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":60,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-08-08T17:00:32.102Z\",\"createdAt\":\"2026-08-08T17:00:32.102Z\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system (CNS) stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate to severe binge eating disorder (BED). It is a prodrug, meaning it is inactive until metabolized by the body into its active form, dextroamphetamine. This medication contains no nutritional value. It carries a boxed warning for high potential for abuse, misuse, and addiction. Common side effects include decreased appetite, insomnia, dry mouth, and headache. Always follow your healthcare provider's instructions, as this is a controlled substance (Schedule II) and should not be shared or used without a prescription.\",\"gramWeight\":0.06,\"hiddenFromFriends\":true,\"id\":\"4D07889D-0324-4DD1-AD34-AD5E123DCD9C\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"Active ingredient: Lisdexamfetamine dimesylate 60 mg per capsule. Inactive ingredients include microcrystalline cellulose, croscarmellose sodium, and magnesium stearate.\",\"nutrients\":{},\"productReference\":{\"activeComponents\":[{\"molecule\":{\"canonicalSMILES\":\"CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"inchiKey\":\"CETWSOHVEGTIBR-FORAGAHYSA-N\",\"isomericSMILES\":\"C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"iupacName\":\"(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide;methanesulfonic acid\",\"molecularFormula\":\"C17H33N3O7S2\",\"molecularWeight\":\"455.6\",\"pubChemCID\":11597697,\"title\":\"Lisdexamfetamine Dimesylate\"},\"name\":\"Lisdexamfetamine Dimesylate\",\"role\":\"Active ingredient\"}],\"brandName\":\"Vyvanse\",\"categoryLabel\":\"Human Prescription Drug\",\"confidence\":\"officialLabel\",\"displayName\":\"Vyvanse\",\"genericName\":\"Lisdexamfetamine Dimesylate\",\"lookedUpAt\":\"2026-08-06T13:57:53.255Z\",\"otherIngredients\":[\"artificial strawberry flavor\",\"colloidal silicon dioxide\",\"croscarmellose sodium\",\"guar gum\",\"magnesium stearate\",\"mannitol\",\"microcrystalline cellulose\",\"sucralose\"],\"query\":\"Vyvanse\",\"sources\":[{\"name\":\"FDA Structured Product Label\",\"url\":\"https://open.fda.gov/apis/drug/label/\"},{\"name\":\"NIH PubChem — Lisdexamfetamine Dimesylate\",\"url\":\"https://pubchem.ncbi.nlm.nih.gov/compound/11597697\"}],\"summary\":\"Vyvanse is an FDA-labeled product containing Lisdexamfetamine Dimesylate.\"},\"quantityWasUserAdjusted\":false,\"servingSize\":60,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-08-08T17:00:32.102Z\",\"useCount\":0}",
      "consumed_timestamp": "2026-08-08T17:00:32.102Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-08-10",
      "recorded_timestamp": "2026-08-11T00:32:37.660Z",
      "local_time": "6:32 AM",
      "meal_id": "D9014477-01E9-482E-B272-08E73950AAB0",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 60,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":60,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-08-10T11:32:37.000Z\",\"createdAt\":\"2026-08-11T00:32:37.660Z\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system (CNS) stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate to severe binge eating disorder (BED). It is a prodrug, meaning it is inactive until metabolized by the body into its active form, dextroamphetamine. This medication contains no nutritional value. It carries a boxed warning for high potential for abuse, misuse, and addiction. Common side effects include decreased appetite, insomnia, dry mouth, and headache. Always follow your healthcare provider's instructions, as this is a controlled substance (Schedule II) and should not be shared or used without a prescription.\",\"gramWeight\":0.06,\"hiddenFromFriends\":true,\"id\":\"98BFFF7D-5502-4BC7-A168-C217807DAB80\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"Active ingredient: Lisdexamfetamine dimesylate 60 mg per capsule. Inactive ingredients include microcrystalline cellulose, croscarmellose sodium, and magnesium stearate.\",\"nutrients\":{},\"productReference\":{\"activeComponents\":[{\"molecule\":{\"canonicalSMILES\":\"CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"inchiKey\":\"CETWSOHVEGTIBR-FORAGAHYSA-N\",\"isomericSMILES\":\"C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"iupacName\":\"(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide;methanesulfonic acid\",\"molecularFormula\":\"C17H33N3O7S2\",\"molecularWeight\":\"455.6\",\"pubChemCID\":11597697,\"title\":\"Lisdexamfetamine Dimesylate\"},\"name\":\"Lisdexamfetamine Dimesylate\",\"role\":\"Active ingredient\"}],\"brandName\":\"Vyvanse\",\"categoryLabel\":\"Human Prescription Drug\",\"confidence\":\"officialLabel\",\"displayName\":\"Vyvanse\",\"genericName\":\"Lisdexamfetamine Dimesylate\",\"lookedUpAt\":\"2026-08-06T13:57:53.255Z\",\"otherIngredients\":[\"artificial strawberry flavor\",\"colloidal silicon dioxide\",\"croscarmellose sodium\",\"guar gum\",\"magnesium stearate\",\"mannitol\",\"microcrystalline cellulose\",\"sucralose\"],\"query\":\"Vyvanse\",\"sources\":[{\"name\":\"FDA Structured Product Label\",\"url\":\"https://open.fda.gov/apis/drug/label/\"},{\"name\":\"NIH PubChem — Lisdexamfetamine Dimesylate\",\"url\":\"https://pubchem.ncbi.nlm.nih.gov/compound/11597697\"}],\"summary\":\"Vyvanse is an FDA-labeled product containing Lisdexamfetamine Dimesylate.\"},\"quantityWasUserAdjusted\":false,\"servingSize\":60,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-08-11T00:32:44.093Z\",\"useCount\":0}",
      "consumed_timestamp": "2026-08-10T11:32:37.000Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-08-11",
      "recorded_timestamp": "2026-08-11T19:22:11.403Z",
      "local_time": "2:22 PM",
      "meal_id": "60E700DF-135D-4581-B5CD-9DC9B07325F7",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 60,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":60,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-08-11T19:22:11.403Z\",\"createdAt\":\"2026-08-11T19:22:11.403Z\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system (CNS) stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate to severe binge eating disorder (BED). It is a prodrug, meaning it is inactive until metabolized by the body into its active form, dextroamphetamine. This medication contains no nutritional value. It carries a boxed warning for high potential for abuse, misuse, and addiction. Common side effects include decreased appetite, insomnia, dry mouth, and headache. Always follow your healthcare provider's instructions, as this is a controlled substance (Schedule II) and should not be shared or used without a prescription.\",\"gramWeight\":0.06,\"hiddenFromFriends\":true,\"id\":\"BB01C028-772E-4C8F-8215-D42C32A2E373\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"Active ingredient: Lisdexamfetamine dimesylate 60 mg per capsule. Inactive ingredients include microcrystalline cellulose, croscarmellose sodium, and magnesium stearate.\",\"nutrients\":{},\"productReference\":{\"activeComponents\":[{\"molecule\":{\"canonicalSMILES\":\"CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"inchiKey\":\"CETWSOHVEGTIBR-FORAGAHYSA-N\",\"isomericSMILES\":\"C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"iupacName\":\"(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide;methanesulfonic acid\",\"molecularFormula\":\"C17H33N3O7S2\",\"molecularWeight\":\"455.6\",\"pubChemCID\":11597697,\"title\":\"Lisdexamfetamine Dimesylate\"},\"name\":\"Lisdexamfetamine Dimesylate\",\"role\":\"Active ingredient\"}],\"brandName\":\"Vyvanse\",\"categoryLabel\":\"Human Prescription Drug\",\"confidence\":\"officialLabel\",\"displayName\":\"Vyvanse\",\"genericName\":\"Lisdexamfetamine Dimesylate\",\"lookedUpAt\":\"2026-08-06T13:57:53.255Z\",\"otherIngredients\":[\"artificial strawberry flavor\",\"colloidal silicon dioxide\",\"croscarmellose sodium\",\"guar gum\",\"magnesium stearate\",\"mannitol\",\"microcrystalline cellulose\",\"sucralose\"],\"query\":\"Vyvanse\",\"sources\":[{\"name\":\"FDA Structured Product Label\",\"url\":\"https://open.fda.gov/apis/drug/label/\"},{\"name\":\"NIH PubChem — Lisdexamfetamine Dimesylate\",\"url\":\"https://pubchem.ncbi.nlm.nih.gov/compound/11597697\"}],\"summary\":\"Vyvanse is an FDA-labeled product containing Lisdexamfetamine Dimesylate.\"},\"quantityWasUserAdjusted\":false,\"servingSize\":60,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-08-11T19:22:11.403Z\",\"useCount\":0}",
      "consumed_timestamp": "2026-08-11T19:22:11.403Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-08-12",
      "recorded_timestamp": "2026-08-12T14:12:06.174Z",
      "local_time": "9:12 AM",
      "meal_id": "87488E29-5BA4-4321-B23D-306F8C2BF823",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 60,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":60,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-08-12T14:12:06.174Z\",\"createdAt\":\"2026-08-12T14:12:06.174Z\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system (CNS) stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate to severe binge eating disorder (BED). It is a prodrug, meaning it is inactive until metabolized by the body into its active form, dextroamphetamine. This medication contains no nutritional value. It carries a boxed warning for high potential for abuse, misuse, and addiction. Common side effects include decreased appetite, insomnia, dry mouth, and headache. Always follow your healthcare provider's instructions, as this is a controlled substance (Schedule II) and should not be shared or used without a prescription.\",\"gramWeight\":0.06,\"hiddenFromFriends\":true,\"id\":\"29CF4905-F7D7-41A8-A8E6-2BCF27A0837E\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"Active ingredient: Lisdexamfetamine dimesylate 60 mg per capsule. Inactive ingredients include microcrystalline cellulose, croscarmellose sodium, and magnesium stearate.\",\"nutrients\":{},\"productReference\":{\"activeComponents\":[{\"molecule\":{\"canonicalSMILES\":\"CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"inchiKey\":\"CETWSOHVEGTIBR-FORAGAHYSA-N\",\"isomericSMILES\":\"C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"iupacName\":\"(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide;methanesulfonic acid\",\"molecularFormula\":\"C17H33N3O7S2\",\"molecularWeight\":\"455.6\",\"pubChemCID\":11597697,\"title\":\"Lisdexamfetamine Dimesylate\"},\"name\":\"Lisdexamfetamine Dimesylate\",\"role\":\"Active ingredient\"}],\"brandName\":\"Vyvanse\",\"categoryLabel\":\"Human Prescription Drug\",\"confidence\":\"officialLabel\",\"displayName\":\"Vyvanse\",\"genericName\":\"Lisdexamfetamine Dimesylate\",\"lookedUpAt\":\"2026-08-06T13:57:53.255Z\",\"otherIngredients\":[\"artificial strawberry flavor\",\"colloidal silicon dioxide\",\"croscarmellose sodium\",\"guar gum\",\"magnesium stearate\",\"mannitol\",\"microcrystalline cellulose\",\"sucralose\"],\"query\":\"Vyvanse\",\"sources\":[{\"name\":\"FDA Structured Product Label\",\"url\":\"https://open.fda.gov/apis/drug/label/\"},{\"name\":\"NIH PubChem — Lisdexamfetamine Dimesylate\",\"url\":\"https://pubchem.ncbi.nlm.nih.gov/compound/11597697\"}],\"summary\":\"Vyvanse is an FDA-labeled product containing Lisdexamfetamine Dimesylate.\"},\"quantityWasUserAdjusted\":false,\"servingSize\":60,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-08-12T14:12:06.174Z\",\"useCount\":0}",
      "consumed_timestamp": "2026-08-12T14:12:06.174Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-08-13",
      "recorded_timestamp": "2026-08-13T20:55:51.045Z",
      "local_time": "12:59 PM",
      "meal_id": "3B15BC16-4288-4235-B65E-2963FC77AE4C",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 60,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":60,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-08-13T17:59:51.000Z\",\"createdAt\":\"2026-08-13T20:55:51.045Z\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system (CNS) stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate to severe binge eating disorder (BED). It is a prodrug, meaning it is inactive until metabolized by the body into its active form, dextroamphetamine. This medication contains no nutritional value. It carries a boxed warning for high potential for abuse, misuse, and addiction. Common side effects include decreased appetite, insomnia, dry mouth, and headache. Always follow your healthcare provider's instructions, as this is a controlled substance (Schedule II) and should not be shared or used without a prescription.\",\"gramWeight\":0.06,\"hiddenFromFriends\":true,\"id\":\"1CDD65A0-086D-47B5-899C-73BAEEEEF504\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"Active ingredient: Lisdexamfetamine dimesylate 60 mg per capsule. Inactive ingredients include microcrystalline cellulose, croscarmellose sodium, and magnesium stearate.\",\"nutrients\":{},\"productReference\":{\"activeComponents\":[{\"molecule\":{\"canonicalSMILES\":\"CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"inchiKey\":\"CETWSOHVEGTIBR-FORAGAHYSA-N\",\"isomericSMILES\":\"C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"iupacName\":\"(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide;methanesulfonic acid\",\"molecularFormula\":\"C17H33N3O7S2\",\"molecularWeight\":\"455.6\",\"pubChemCID\":11597697,\"title\":\"Lisdexamfetamine Dimesylate\"},\"name\":\"Lisdexamfetamine Dimesylate\",\"role\":\"Active ingredient\"}],\"brandName\":\"Vyvanse\",\"categoryLabel\":\"Human Prescription Drug\",\"confidence\":\"officialLabel\",\"displayName\":\"Vyvanse\",\"genericName\":\"Lisdexamfetamine Dimesylate\",\"lookedUpAt\":\"2026-08-06T13:57:53.255Z\",\"otherIngredients\":[\"artificial strawberry flavor\",\"colloidal silicon dioxide\",\"croscarmellose sodium\",\"guar gum\",\"magnesium stearate\",\"mannitol\",\"microcrystalline cellulose\",\"sucralose\"],\"query\":\"Vyvanse\",\"sources\":[{\"name\":\"FDA Structured Product Label\",\"url\":\"https://open.fda.gov/apis/drug/label/\"},{\"name\":\"NIH PubChem — Lisdexamfetamine Dimesylate\",\"url\":\"https://pubchem.ncbi.nlm.nih.gov/compound/11597697\"}],\"summary\":\"Vyvanse is an FDA-labeled product containing Lisdexamfetamine Dimesylate.\"},\"quantityWasUserAdjusted\":false,\"servingSize\":60,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-08-13T20:56:00.705Z\",\"useCount\":0}",
      "consumed_timestamp": "2026-08-13T17:59:51.000Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-08-15",
      "recorded_timestamp": "2026-08-15T16:17:51.452Z",
      "local_time": "11:17 AM",
      "meal_id": "71A879E0-253C-4DE3-865D-F44449051C4C",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 60,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":60,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-08-15T16:17:51.452Z\",\"createdAt\":\"2026-08-15T16:17:51.452Z\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system (CNS) stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate to severe binge eating disorder (BED). It is a prodrug, meaning it is inactive until metabolized by the body into its active form, dextroamphetamine. This medication contains no nutritional value. It carries a boxed warning for high potential for abuse, misuse, and addiction. Common side effects include decreased appetite, insomnia, dry mouth, and headache. Always follow your healthcare provider's instructions, as this is a controlled substance (Schedule II) and should not be shared or used without a prescription.\",\"gramWeight\":0.06,\"hiddenFromFriends\":true,\"id\":\"86629D76-F30E-49C6-A12B-84422947CD2E\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"Active ingredient: Lisdexamfetamine dimesylate 60 mg per capsule. Inactive ingredients include microcrystalline cellulose, croscarmellose sodium, and magnesium stearate.\",\"nutrients\":{},\"productReference\":{\"activeComponents\":[{\"molecule\":{\"canonicalSMILES\":\"CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"inchiKey\":\"CETWSOHVEGTIBR-FORAGAHYSA-N\",\"isomericSMILES\":\"C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"iupacName\":\"(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide;methanesulfonic acid\",\"molecularFormula\":\"C17H33N3O7S2\",\"molecularWeight\":\"455.6\",\"pubChemCID\":11597697,\"title\":\"Lisdexamfetamine Dimesylate\"},\"name\":\"Lisdexamfetamine Dimesylate\",\"role\":\"Active ingredient\"}],\"brandName\":\"Vyvanse\",\"categoryLabel\":\"Human Prescription Drug\",\"confidence\":\"officialLabel\",\"displayName\":\"Vyvanse\",\"genericName\":\"Lisdexamfetamine Dimesylate\",\"lookedUpAt\":\"2026-08-06T13:57:53.255Z\",\"otherIngredients\":[\"artificial strawberry flavor\",\"colloidal silicon dioxide\",\"croscarmellose sodium\",\"guar gum\",\"magnesium stearate\",\"mannitol\",\"microcrystalline cellulose\",\"sucralose\"],\"query\":\"Vyvanse\",\"sources\":[{\"name\":\"FDA Structured Product Label\",\"url\":\"https://open.fda.gov/apis/drug/label/\"},{\"name\":\"NIH PubChem — Lisdexamfetamine Dimesylate\",\"url\":\"https://pubchem.ncbi.nlm.nih.gov/compound/11597697\"}],\"summary\":\"Vyvanse is an FDA-labeled product containing Lisdexamfetamine Dimesylate.\"},\"quantityWasUserAdjusted\":false,\"servingSize\":60,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-08-15T16:17:51.452Z\",\"useCount\":0}",
      "consumed_timestamp": "2026-08-15T16:17:51.452Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-08-16",
      "recorded_timestamp": "2026-08-16T17:50:15.294Z",
      "local_time": "11:15 AM",
      "meal_id": "D46EAFD0-AB2B-41FC-B62C-662A0D7D6202",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 60,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":60,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-08-16T16:15:15.000Z\",\"createdAt\":\"2026-08-16T17:50:15.294Z\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system (CNS) stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate to severe binge eating disorder (BED). It is a prodrug, meaning it is inactive until metabolized by the body into its active form, dextroamphetamine. This medication contains no nutritional value. It carries a boxed warning for high potential for abuse, misuse, and addiction. Common side effects include decreased appetite, insomnia, dry mouth, and headache. Always follow your healthcare provider's instructions, as this is a controlled substance (Schedule II) and should not be shared or used without a prescription.\",\"gramWeight\":0.06,\"hiddenFromFriends\":true,\"id\":\"D14B9C3D-BF0E-48B2-96B3-1A159ACA7C15\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"Active ingredient: Lisdexamfetamine dimesylate 60 mg per capsule. Inactive ingredients include microcrystalline cellulose, croscarmellose sodium, and magnesium stearate.\",\"nutrients\":{},\"productReference\":{\"activeComponents\":[{\"molecule\":{\"canonicalSMILES\":\"CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"inchiKey\":\"CETWSOHVEGTIBR-FORAGAHYSA-N\",\"isomericSMILES\":\"C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"iupacName\":\"(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide;methanesulfonic acid\",\"molecularFormula\":\"C17H33N3O7S2\",\"molecularWeight\":\"455.6\",\"pubChemCID\":11597697,\"title\":\"Lisdexamfetamine Dimesylate\"},\"name\":\"Lisdexamfetamine Dimesylate\",\"role\":\"Active ingredient\"}],\"brandName\":\"Vyvanse\",\"categoryLabel\":\"Human Prescription Drug\",\"confidence\":\"officialLabel\",\"displayName\":\"Vyvanse\",\"genericName\":\"Lisdexamfetamine Dimesylate\",\"lookedUpAt\":\"2026-08-06T13:57:53.255Z\",\"otherIngredients\":[\"artificial strawberry flavor\",\"colloidal silicon dioxide\",\"croscarmellose sodium\",\"guar gum\",\"magnesium stearate\",\"mannitol\",\"microcrystalline cellulose\",\"sucralose\"],\"query\":\"Vyvanse\",\"sources\":[{\"name\":\"FDA Structured Product Label\",\"url\":\"https://open.fda.gov/apis/drug/label/\"},{\"name\":\"NIH PubChem — Lisdexamfetamine Dimesylate\",\"url\":\"https://pubchem.ncbi.nlm.nih.gov/compound/11597697\"}],\"summary\":\"Vyvanse is an FDA-labeled product containing Lisdexamfetamine Dimesylate.\"},\"quantityWasUserAdjusted\":false,\"servingSize\":60,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-08-16T17:50:23.446Z\",\"useCount\":0}",
      "consumed_timestamp": "2026-08-16T16:15:15.000Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-08-17",
      "recorded_timestamp": "2026-08-18T02:14:04.497Z",
      "local_time": "10:28 AM",
      "meal_id": "7D2A5A42-7FBE-4A35-A785-6A0F82436E8D",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 60,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":60,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-08-17T15:28:04.000Z\",\"createdAt\":\"2026-08-18T02:14:04.497Z\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system (CNS) stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate to severe binge eating disorder (BED). It is a prodrug, meaning it is inactive until metabolized by the body into its active form, dextroamphetamine. This medication contains no nutritional value. It carries a boxed warning for high potential for abuse, misuse, and addiction. Common side effects include decreased appetite, insomnia, dry mouth, and headache. Always follow your healthcare provider's instructions, as this is a controlled substance (Schedule II) and should not be shared or used without a prescription.\",\"gramWeight\":0.06,\"hiddenFromFriends\":true,\"id\":\"55630889-F442-427D-9A97-D00837F230CA\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"Active ingredient: Lisdexamfetamine dimesylate 60 mg per capsule. Inactive ingredients include microcrystalline cellulose, croscarmellose sodium, and magnesium stearate.\",\"nutrients\":{},\"productReference\":{\"activeComponents\":[{\"molecule\":{\"canonicalSMILES\":\"CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"inchiKey\":\"CETWSOHVEGTIBR-FORAGAHYSA-N\",\"isomericSMILES\":\"C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"iupacName\":\"(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide;methanesulfonic acid\",\"molecularFormula\":\"C17H33N3O7S2\",\"molecularWeight\":\"455.6\",\"pubChemCID\":11597697,\"title\":\"Lisdexamfetamine Dimesylate\"},\"name\":\"Lisdexamfetamine Dimesylate\",\"role\":\"Active ingredient\"}],\"brandName\":\"Vyvanse\",\"categoryLabel\":\"Human Prescription Drug\",\"confidence\":\"officialLabel\",\"displayName\":\"Vyvanse\",\"genericName\":\"Lisdexamfetamine Dimesylate\",\"lookedUpAt\":\"2026-08-06T13:57:53.255Z\",\"otherIngredients\":[\"artificial strawberry flavor\",\"colloidal silicon dioxide\",\"croscarmellose sodium\",\"guar gum\",\"magnesium stearate\",\"mannitol\",\"microcrystalline cellulose\",\"sucralose\"],\"query\":\"Vyvanse\",\"sources\":[{\"name\":\"FDA Structured Product Label\",\"url\":\"https://open.fda.gov/apis/drug/label/\"},{\"name\":\"NIH PubChem — Lisdexamfetamine Dimesylate\",\"url\":\"https://pubchem.ncbi.nlm.nih.gov/compound/11597697\"}],\"summary\":\"Vyvanse is an FDA-labeled product containing Lisdexamfetamine Dimesylate.\"},\"quantityWasUserAdjusted\":false,\"servingSize\":60,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-08-18T02:14:14.882Z\",\"useCount\":0}",
      "consumed_timestamp": "2026-08-17T15:28:04.000Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-08-19",
      "recorded_timestamp": "2026-08-19T16:51:24.578Z",
      "local_time": "11:51 AM",
      "meal_id": "68580E93-AFBD-4495-9953-D830D9A4BFB3",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 60,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":60,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-08-19T16:51:24.578Z\",\"createdAt\":\"2026-08-19T16:51:24.578Z\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system (CNS) stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate to severe binge eating disorder (BED). It is a prodrug, meaning it is inactive until metabolized by the body into its active form, dextroamphetamine. This medication contains no nutritional value. It carries a boxed warning for high potential for abuse, misuse, and addiction. Common side effects include decreased appetite, insomnia, dry mouth, and headache. Always follow your healthcare provider's instructions, as this is a controlled substance (Schedule II) and should not be shared or used without a prescription.\",\"gramWeight\":0.06,\"hiddenFromFriends\":true,\"id\":\"67F20321-051F-4C10-97D7-6A6F5265DF93\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"Active ingredient: Lisdexamfetamine dimesylate 60 mg per capsule. Inactive ingredients include microcrystalline cellulose, croscarmellose sodium, and magnesium stearate.\",\"nutrients\":{},\"productReference\":{\"activeComponents\":[{\"molecule\":{\"canonicalSMILES\":\"CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"inchiKey\":\"CETWSOHVEGTIBR-FORAGAHYSA-N\",\"isomericSMILES\":\"C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"iupacName\":\"(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide;methanesulfonic acid\",\"molecularFormula\":\"C17H33N3O7S2\",\"molecularWeight\":\"455.6\",\"pubChemCID\":11597697,\"title\":\"Lisdexamfetamine Dimesylate\"},\"name\":\"Lisdexamfetamine Dimesylate\",\"role\":\"Active ingredient\"}],\"brandName\":\"Vyvanse\",\"categoryLabel\":\"Human Prescription Drug\",\"confidence\":\"officialLabel\",\"displayName\":\"Vyvanse\",\"genericName\":\"Lisdexamfetamine Dimesylate\",\"lookedUpAt\":\"2026-08-06T13:57:53.255Z\",\"otherIngredients\":[\"artificial strawberry flavor\",\"colloidal silicon dioxide\",\"croscarmellose sodium\",\"guar gum\",\"magnesium stearate\",\"mannitol\",\"microcrystalline cellulose\",\"sucralose\"],\"query\":\"Vyvanse\",\"sources\":[{\"name\":\"FDA Structured Product Label\",\"url\":\"https://open.fda.gov/apis/drug/label/\"},{\"name\":\"NIH PubChem — Lisdexamfetamine Dimesylate\",\"url\":\"https://pubchem.ncbi.nlm.nih.gov/compound/11597697\"}],\"summary\":\"Vyvanse is an FDA-labeled product containing Lisdexamfetamine Dimesylate.\"},\"quantityWasUserAdjusted\":false,\"servingSize\":60,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-08-19T16:51:24.578Z\",\"useCount\":0}",
      "consumed_timestamp": "2026-08-19T16:51:24.578Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-08-20",
      "recorded_timestamp": "2026-08-21T00:29:02.575Z",
      "local_time": "10:29 AM",
      "meal_id": "1E3A8BF0-5628-4400-920F-0CDC918AA34F",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 60,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":60,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-08-20T15:29:02.000Z\",\"createdAt\":\"2026-08-21T00:29:02.575Z\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system (CNS) stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate to severe binge eating disorder (BED). It is a prodrug, meaning it is inactive until metabolized by the body into its active form, dextroamphetamine. This medication contains no nutritional value. It carries a boxed warning for high potential for abuse, misuse, and addiction. Common side effects include decreased appetite, insomnia, dry mouth, and headache. Always follow your healthcare provider's instructions, as this is a controlled substance (Schedule II) and should not be shared or used without a prescription.\",\"gramWeight\":0.06,\"hiddenFromFriends\":true,\"id\":\"EEAC871D-10A7-477E-9CD9-F2AA66AF97F3\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"Active ingredient: Lisdexamfetamine dimesylate 60 mg per capsule. Inactive ingredients include microcrystalline cellulose, croscarmellose sodium, and magnesium stearate.\",\"nutrients\":{},\"productReference\":{\"activeComponents\":[{\"molecule\":{\"canonicalSMILES\":\"CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"inchiKey\":\"CETWSOHVEGTIBR-FORAGAHYSA-N\",\"isomericSMILES\":\"C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"iupacName\":\"(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide;methanesulfonic acid\",\"molecularFormula\":\"C17H33N3O7S2\",\"molecularWeight\":\"455.6\",\"pubChemCID\":11597697,\"title\":\"Lisdexamfetamine Dimesylate\"},\"name\":\"Lisdexamfetamine Dimesylate\",\"role\":\"Active ingredient\"}],\"brandName\":\"Vyvanse\",\"categoryLabel\":\"Human Prescription Drug\",\"confidence\":\"officialLabel\",\"displayName\":\"Vyvanse\",\"genericName\":\"Lisdexamfetamine Dimesylate\",\"lookedUpAt\":\"2026-08-06T13:57:53.255Z\",\"otherIngredients\":[\"artificial strawberry flavor\",\"colloidal silicon dioxide\",\"croscarmellose sodium\",\"guar gum\",\"magnesium stearate\",\"mannitol\",\"microcrystalline cellulose\",\"sucralose\"],\"query\":\"Vyvanse\",\"sources\":[{\"name\":\"FDA Structured Product Label\",\"url\":\"https://open.fda.gov/apis/drug/label/\"},{\"name\":\"NIH PubChem — Lisdexamfetamine Dimesylate\",\"url\":\"https://pubchem.ncbi.nlm.nih.gov/compound/11597697\"}],\"summary\":\"Vyvanse is an FDA-labeled product containing Lisdexamfetamine Dimesylate.\"},\"quantityWasUserAdjusted\":false,\"servingSize\":60,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-08-21T00:29:10.717Z\",\"useCount\":0}",
      "consumed_timestamp": "2026-08-20T15:29:02.000Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-08-21",
      "recorded_timestamp": "2026-08-21T16:44:45.401Z",
      "local_time": "11:44 AM",
      "meal_id": "BA7C375C-516D-4CCD-96F8-1A0509F163CA",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 60,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":60,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-08-21T16:44:45.401Z\",\"createdAt\":\"2026-08-21T16:44:45.401Z\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system (CNS) stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate to severe binge eating disorder (BED). It is a prodrug, meaning it is inactive until metabolized by the body into its active form, dextroamphetamine. This medication contains no nutritional value. It carries a boxed warning for high potential for abuse, misuse, and addiction. Common side effects include decreased appetite, insomnia, dry mouth, and headache. Always follow your healthcare provider's instructions, as this is a controlled substance (Schedule II) and should not be shared or used without a prescription.\",\"gramWeight\":0.06,\"hiddenFromFriends\":true,\"id\":\"B1614E8D-8B97-412A-AABC-84FE816158B9\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"Active ingredient: Lisdexamfetamine dimesylate 60 mg per capsule. Inactive ingredients include microcrystalline cellulose, croscarmellose sodium, and magnesium stearate.\",\"nutrients\":{},\"productReference\":{\"activeComponents\":[{\"molecule\":{\"canonicalSMILES\":\"CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"inchiKey\":\"CETWSOHVEGTIBR-FORAGAHYSA-N\",\"isomericSMILES\":\"C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"iupacName\":\"(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide;methanesulfonic acid\",\"molecularFormula\":\"C17H33N3O7S2\",\"molecularWeight\":\"455.6\",\"pubChemCID\":11597697,\"title\":\"Lisdexamfetamine Dimesylate\"},\"name\":\"Lisdexamfetamine Dimesylate\",\"role\":\"Active ingredient\"}],\"brandName\":\"Vyvanse\",\"categoryLabel\":\"Human Prescription Drug\",\"confidence\":\"officialLabel\",\"displayName\":\"Vyvanse\",\"genericName\":\"Lisdexamfetamine Dimesylate\",\"lookedUpAt\":\"2026-08-06T13:57:53.255Z\",\"otherIngredients\":[\"artificial strawberry flavor\",\"colloidal silicon dioxide\",\"croscarmellose sodium\",\"guar gum\",\"magnesium stearate\",\"mannitol\",\"microcrystalline cellulose\",\"sucralose\"],\"query\":\"Vyvanse\",\"sources\":[{\"name\":\"FDA Structured Product Label\",\"url\":\"https://open.fda.gov/apis/drug/label/\"},{\"name\":\"NIH PubChem — Lisdexamfetamine Dimesylate\",\"url\":\"https://pubchem.ncbi.nlm.nih.gov/compound/11597697\"}],\"summary\":\"Vyvanse is an FDA-labeled product containing Lisdexamfetamine Dimesylate.\"},\"quantityWasUserAdjusted\":false,\"servingSize\":60,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-08-21T16:44:45.401Z\",\"useCount\":0}",
      "consumed_timestamp": "2026-08-21T16:44:45.401Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-08-23",
      "recorded_timestamp": "2026-08-23T19:37:27.162Z",
      "local_time": "11:22 AM",
      "meal_id": "C077A816-55D8-41E7-99D6-9A2DC669EAE6",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 60,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":60,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-08-23T16:22:27.000Z\",\"createdAt\":\"2026-08-23T19:37:27.162Z\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system (CNS) stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate to severe binge eating disorder (BED). It is a prodrug, meaning it is inactive until metabolized by the body into its active form, dextroamphetamine. This medication contains no nutritional value. It carries a boxed warning for high potential for abuse, misuse, and addiction. Common side effects include decreased appetite, insomnia, dry mouth, and headache. Always follow your healthcare provider's instructions, as this is a controlled substance (Schedule II) and should not be shared or used without a prescription.\",\"gramWeight\":0.06,\"hiddenFromFriends\":true,\"id\":\"1DE9994C-9950-4445-930C-86BF25226943\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"Active ingredient: Lisdexamfetamine dimesylate 60 mg per capsule. Inactive ingredients include microcrystalline cellulose, croscarmellose sodium, and magnesium stearate.\",\"nutrients\":{},\"productReference\":{\"activeComponents\":[{\"molecule\":{\"canonicalSMILES\":\"CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"inchiKey\":\"CETWSOHVEGTIBR-FORAGAHYSA-N\",\"isomericSMILES\":\"C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"iupacName\":\"(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide;methanesulfonic acid\",\"molecularFormula\":\"C17H33N3O7S2\",\"molecularWeight\":\"455.6\",\"pubChemCID\":11597697,\"title\":\"Lisdexamfetamine Dimesylate\"},\"name\":\"Lisdexamfetamine Dimesylate\",\"role\":\"Active ingredient\"}],\"brandName\":\"Vyvanse\",\"categoryLabel\":\"Human Prescription Drug\",\"confidence\":\"officialLabel\",\"displayName\":\"Vyvanse\",\"genericName\":\"Lisdexamfetamine Dimesylate\",\"lookedUpAt\":\"2026-08-06T13:57:53.255Z\",\"otherIngredients\":[\"artificial strawberry flavor\",\"colloidal silicon dioxide\",\"croscarmellose sodium\",\"guar gum\",\"magnesium stearate\",\"mannitol\",\"microcrystalline cellulose\",\"sucralose\"],\"query\":\"Vyvanse\",\"sources\":[{\"name\":\"FDA Structured Product Label\",\"url\":\"https://open.fda.gov/apis/drug/label/\"},{\"name\":\"NIH PubChem — Lisdexamfetamine Dimesylate\",\"url\":\"https://pubchem.ncbi.nlm.nih.gov/compound/11597697\"}],\"summary\":\"Vyvanse is an FDA-labeled product containing Lisdexamfetamine Dimesylate.\"},\"quantityWasUserAdjusted\":false,\"servingSize\":60,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-08-23T19:37:34.473Z\",\"useCount\":0}",
      "consumed_timestamp": "2026-08-23T16:22:27.000Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-08-24",
      "recorded_timestamp": "2026-08-24T16:03:42.370Z",
      "local_time": "11:03 AM",
      "meal_id": "170396A8-8818-49B2-89C9-7D52494C3E94",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 60,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":60,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-08-24T16:03:42.370Z\",\"createdAt\":\"2026-08-24T16:03:42.370Z\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system (CNS) stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate to severe binge eating disorder (BED). It is a prodrug, meaning it is inactive until metabolized by the body into its active form, dextroamphetamine. This medication contains no nutritional value. It carries a boxed warning for high potential for abuse, misuse, and addiction. Common side effects include decreased appetite, insomnia, dry mouth, and headache. Always follow your healthcare provider's instructions, as this is a controlled substance (Schedule II) and should not be shared or used without a prescription.\",\"gramWeight\":0.06,\"hiddenFromFriends\":true,\"id\":\"86034CFA-92DB-4F33-8E57-B0BAE3B9C1BB\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"Active ingredient: Lisdexamfetamine dimesylate 60 mg per capsule. Inactive ingredients include microcrystalline cellulose, croscarmellose sodium, and magnesium stearate.\",\"nutrients\":{},\"productReference\":{\"activeComponents\":[{\"molecule\":{\"canonicalSMILES\":\"CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"inchiKey\":\"CETWSOHVEGTIBR-FORAGAHYSA-N\",\"isomericSMILES\":\"C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"iupacName\":\"(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide;methanesulfonic acid\",\"molecularFormula\":\"C17H33N3O7S2\",\"molecularWeight\":\"455.6\",\"pubChemCID\":11597697,\"title\":\"Lisdexamfetamine Dimesylate\"},\"name\":\"Lisdexamfetamine Dimesylate\",\"role\":\"Active ingredient\"}],\"brandName\":\"Vyvanse\",\"categoryLabel\":\"Human Prescription Drug\",\"confidence\":\"officialLabel\",\"displayName\":\"Vyvanse\",\"genericName\":\"Lisdexamfetamine Dimesylate\",\"lookedUpAt\":\"2026-08-06T13:57:53.255Z\",\"otherIngredients\":[\"artificial strawberry flavor\",\"colloidal silicon dioxide\",\"croscarmellose sodium\",\"guar gum\",\"magnesium stearate\",\"mannitol\",\"microcrystalline cellulose\",\"sucralose\"],\"query\":\"Vyvanse\",\"sources\":[{\"name\":\"FDA Structured Product Label\",\"url\":\"https://open.fda.gov/apis/drug/label/\"},{\"name\":\"NIH PubChem — Lisdexamfetamine Dimesylate\",\"url\":\"https://pubchem.ncbi.nlm.nih.gov/compound/11597697\"}],\"summary\":\"Vyvanse is an FDA-labeled product containing Lisdexamfetamine Dimesylate.\"},\"quantityWasUserAdjusted\":false,\"servingSize\":60,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"medium\",\"identityEvidence\":\"userEntered\",\"notes\":[\"User-entered record; trust depends on entry accuracy.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-08-24T16:03:42.370Z\",\"useCount\":0}",
      "consumed_timestamp": "2026-08-24T16:03:42.370Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-08-26",
      "recorded_timestamp": "2026-08-26T21:22:57.150Z",
      "local_time": "11:22 AM",
      "meal_id": "6D704F4F-CDDE-4F1F-BC3F-492ED7FB2B07",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 60,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":60,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-08-26T16:22:57.000Z\",\"createdAt\":\"2026-08-26T21:22:57.150Z\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system (CNS) stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate to severe binge eating disorder (BED). It is a prodrug, meaning it is inactive until metabolized by the body into its active form, dextroamphetamine. This medication contains no nutritional value. It carries a boxed warning for high potential for abuse, misuse, and addiction. Common side effects include decreased appetite, insomnia, dry mouth, and headache. Always follow your healthcare provider's instructions, as this is a controlled substance (Schedule II) and should not be shared or used without a prescription.\",\"gramWeight\":0.06,\"hiddenFromFriends\":true,\"id\":\"2904D831-74BC-445D-911D-5F02E1F90C05\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"Active ingredient: Lisdexamfetamine dimesylate 60 mg per capsule. Inactive ingredients include microcrystalline cellulose, croscarmellose sodium, and magnesium stearate.\",\"nutrients\":{},\"productReference\":{\"activeComponents\":[{\"molecule\":{\"canonicalSMILES\":\"CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"inchiKey\":\"CETWSOHVEGTIBR-FORAGAHYSA-N\",\"isomericSMILES\":\"C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"iupacName\":\"(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide;methanesulfonic acid\",\"molecularFormula\":\"C17H33N3O7S2\",\"molecularWeight\":\"455.6\",\"pubChemCID\":11597697,\"title\":\"Lisdexamfetamine Dimesylate\"},\"name\":\"Lisdexamfetamine Dimesylate\",\"role\":\"Active ingredient\"}],\"brandName\":\"Vyvanse\",\"categoryLabel\":\"Human Prescription Drug\",\"confidence\":\"officialLabel\",\"displayName\":\"Vyvanse\",\"genericName\":\"Lisdexamfetamine Dimesylate\",\"lookedUpAt\":\"2026-08-06T13:57:53.255Z\",\"otherIngredients\":[\"artificial strawberry flavor\",\"colloidal silicon dioxide\",\"croscarmellose sodium\",\"guar gum\",\"magnesium stearate\",\"mannitol\",\"microcrystalline cellulose\",\"sucralose\"],\"query\":\"Vyvanse\",\"sources\":[{\"name\":\"FDA Structured Product Label\",\"url\":\"https://open.fda.gov/apis/drug/label/\"},{\"name\":\"NIH PubChem — Lisdexamfetamine Dimesylate\",\"url\":\"https://pubchem.ncbi.nlm.nih.gov/compound/11597697\"}],\"summary\":\"Vyvanse is an FDA-labeled product containing Lisdexamfetamine Dimesylate.\"},\"quantityWasUserAdjusted\":false,\"servingSize\":60,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"high\",\"identityEvidence\":\"nutritionLabel\",\"notes\":[\"Supplement label values retained with their product reference.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-08-26T21:23:03.909Z\",\"useCount\":0}",
      "consumed_timestamp": "2026-08-26T16:22:57.000Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-08-29",
      "recorded_timestamp": "2026-08-29T17:03:06.577Z",
      "local_time": "12:03 PM",
      "meal_id": "BB7922A3-9B79-40E2-8368-F0AAC0A5FE2B",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 60,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":60,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-08-29T17:03:06.577Z\",\"createdAt\":\"2026-08-29T17:03:06.577Z\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system (CNS) stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate to severe binge eating disorder (BED). It is a prodrug, meaning it is inactive until metabolized by the body into its active form, dextroamphetamine. This medication contains no nutritional value. It carries a boxed warning for high potential for abuse, misuse, and addiction. Common side effects include decreased appetite, insomnia, dry mouth, and headache. Always follow your healthcare provider's instructions, as this is a controlled substance (Schedule II) and should not be shared or used without a prescription.\",\"gramWeight\":0.06,\"hiddenFromFriends\":true,\"id\":\"31B314B4-4639-4BCC-91A4-0F999082FA96\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"Active ingredient: Lisdexamfetamine dimesylate 60 mg per capsule. Inactive ingredients include microcrystalline cellulose, croscarmellose sodium, and magnesium stearate.\",\"nutrients\":{},\"productReference\":{\"activeComponents\":[{\"molecule\":{\"canonicalSMILES\":\"CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"inchiKey\":\"CETWSOHVEGTIBR-FORAGAHYSA-N\",\"isomericSMILES\":\"C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"iupacName\":\"(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide;methanesulfonic acid\",\"molecularFormula\":\"C17H33N3O7S2\",\"molecularWeight\":\"455.6\",\"pubChemCID\":11597697,\"title\":\"Lisdexamfetamine Dimesylate\"},\"name\":\"Lisdexamfetamine Dimesylate\",\"role\":\"Active ingredient\"}],\"brandName\":\"Vyvanse\",\"categoryLabel\":\"Human Prescription Drug\",\"confidence\":\"officialLabel\",\"displayName\":\"Vyvanse\",\"genericName\":\"Lisdexamfetamine Dimesylate\",\"lookedUpAt\":\"2026-08-06T13:57:53.255Z\",\"otherIngredients\":[\"artificial strawberry flavor\",\"colloidal silicon dioxide\",\"croscarmellose sodium\",\"guar gum\",\"magnesium stearate\",\"mannitol\",\"microcrystalline cellulose\",\"sucralose\"],\"query\":\"Vyvanse\",\"sources\":[{\"name\":\"FDA Structured Product Label\",\"url\":\"https://open.fda.gov/apis/drug/label/\"},{\"name\":\"NIH PubChem — Lisdexamfetamine Dimesylate\",\"url\":\"https://pubchem.ncbi.nlm.nih.gov/compound/11597697\"}],\"summary\":\"Vyvanse is an FDA-labeled product containing Lisdexamfetamine Dimesylate.\"},\"quantityWasUserAdjusted\":false,\"servingSize\":60,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"high\",\"identityEvidence\":\"nutritionLabel\",\"notes\":[\"Supplement label values retained with their product reference.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-08-29T17:03:06.577Z\",\"useCount\":0}",
      "consumed_timestamp": "2026-08-29T17:03:06.577Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-08-30",
      "recorded_timestamp": "2026-08-30T17:12:12.969Z",
      "local_time": "7:33 AM",
      "meal_id": "6E2B523B-9137-4119-B470-BCAE447DFE45",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 60,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":60,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-08-30T12:33:12.000Z\",\"createdAt\":\"2026-08-30T17:12:12.969Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system (CNS) stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate to severe binge eating disorder (BED). It is a prodrug, meaning it is inactive until metabolized by the body into its active form, dextroamphetamine. This medication contains no nutritional value. It carries a boxed warning for high potential for abuse, misuse, and addiction. Common side effects include decreased appetite, insomnia, dry mouth, and headache. Always follow your healthcare provider's instructions, as this is a controlled substance (Schedule II) and should not be shared or used without a prescription.\",\"gramWeight\":0.06,\"hiddenFromFriends\":true,\"id\":\"6C033BCE-1D08-475C-9D54-F222230E6EC7\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"Active ingredient: Lisdexamfetamine dimesylate 60 mg per capsule. Inactive ingredients include microcrystalline cellulose, croscarmellose sodium, and magnesium stearate.\",\"nutrients\":{},\"productReference\":{\"activeComponents\":[{\"molecule\":{\"canonicalSMILES\":\"CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"inchiKey\":\"CETWSOHVEGTIBR-FORAGAHYSA-N\",\"isomericSMILES\":\"C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"iupacName\":\"(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide;methanesulfonic acid\",\"molecularFormula\":\"C17H33N3O7S2\",\"molecularWeight\":\"455.6\",\"pubChemCID\":11597697,\"title\":\"Lisdexamfetamine Dimesylate\"},\"name\":\"Lisdexamfetamine Dimesylate\",\"role\":\"Active ingredient\"}],\"brandName\":\"Vyvanse\",\"categoryLabel\":\"Human Prescription Drug\",\"confidence\":\"officialLabel\",\"displayName\":\"Vyvanse\",\"genericName\":\"Lisdexamfetamine Dimesylate\",\"lookedUpAt\":\"2026-08-06T13:57:53.255Z\",\"otherIngredients\":[\"artificial strawberry flavor\",\"colloidal silicon dioxide\",\"croscarmellose sodium\",\"guar gum\",\"magnesium stearate\",\"mannitol\",\"microcrystalline cellulose\",\"sucralose\"],\"query\":\"Vyvanse\",\"sources\":[{\"name\":\"FDA Structured Product Label\",\"url\":\"https://open.fda.gov/apis/drug/label/\"},{\"name\":\"NIH PubChem — Lisdexamfetamine Dimesylate\",\"url\":\"https://pubchem.ncbi.nlm.nih.gov/compound/11597697\"}],\"summary\":\"Vyvanse is an FDA-labeled product containing Lisdexamfetamine Dimesylate.\"},\"quantityWasUserAdjusted\":false,\"servingSize\":60,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"high\",\"identityEvidence\":\"nutritionLabel\",\"notes\":[\"Supplement label values retained with their product reference.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-08-30T17:12:26.146Z\",\"useCount\":0}",
      "consumed_timestamp": "2026-08-30T12:33:12.000Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-08-31",
      "recorded_timestamp": "2026-08-31T21:12:41.129Z",
      "local_time": "11:12 AM",
      "meal_id": "180A75A3-80DF-4EC5-85D8-CB327AC48DB9",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 60,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":60,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-08-31T16:12:41.000Z\",\"createdAt\":\"2026-08-31T21:12:41.129Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system (CNS) stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate to severe binge eating disorder (BED). It is a prodrug, meaning it is inactive until metabolized by the body into its active form, dextroamphetamine. This medication contains no nutritional value. It carries a boxed warning for high potential for abuse, misuse, and addiction. Common side effects include decreased appetite, insomnia, dry mouth, and headache. Always follow your healthcare provider's instructions, as this is a controlled substance (Schedule II) and should not be shared or used without a prescription.\",\"gramWeight\":0.06,\"hiddenFromFriends\":true,\"id\":\"97E0AF9F-DAB0-4EFD-B194-B2D0C53F4FEE\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"Active ingredient: Lisdexamfetamine dimesylate 60 mg per capsule. Inactive ingredients include microcrystalline cellulose, croscarmellose sodium, and magnesium stearate.\",\"nutrients\":{},\"productReference\":{\"activeComponents\":[{\"molecule\":{\"canonicalSMILES\":\"CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"inchiKey\":\"CETWSOHVEGTIBR-FORAGAHYSA-N\",\"isomericSMILES\":\"C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"iupacName\":\"(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide;methanesulfonic acid\",\"molecularFormula\":\"C17H33N3O7S2\",\"molecularWeight\":\"455.6\",\"pubChemCID\":11597697,\"title\":\"Lisdexamfetamine Dimesylate\"},\"name\":\"Lisdexamfetamine Dimesylate\",\"role\":\"Active ingredient\"}],\"brandName\":\"Vyvanse\",\"categoryLabel\":\"Human Prescription Drug\",\"confidence\":\"officialLabel\",\"displayName\":\"Vyvanse\",\"genericName\":\"Lisdexamfetamine Dimesylate\",\"lookedUpAt\":\"2026-08-06T13:57:53.255Z\",\"otherIngredients\":[\"artificial strawberry flavor\",\"colloidal silicon dioxide\",\"croscarmellose sodium\",\"guar gum\",\"magnesium stearate\",\"mannitol\",\"microcrystalline cellulose\",\"sucralose\"],\"query\":\"Vyvanse\",\"sources\":[{\"name\":\"FDA Structured Product Label\",\"url\":\"https://open.fda.gov/apis/drug/label/\"},{\"name\":\"NIH PubChem — Lisdexamfetamine Dimesylate\",\"url\":\"https://pubchem.ncbi.nlm.nih.gov/compound/11597697\"}],\"summary\":\"Vyvanse is an FDA-labeled product containing Lisdexamfetamine Dimesylate.\"},\"quantityWasUserAdjusted\":false,\"servingSize\":60,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"high\",\"identityEvidence\":\"nutritionLabel\",\"notes\":[\"Supplement label values retained with their product reference.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-08-31T21:12:47.338Z\",\"useCount\":0}",
      "consumed_timestamp": "2026-08-31T16:12:41.000Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-09-01",
      "recorded_timestamp": "2026-09-01T16:12:33.297Z",
      "local_time": "11:12 AM",
      "meal_id": "4EA12E5B-33C9-48B4-B669-1F93DDC129BB",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 60,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":60,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-09-01T16:12:33.297Z\",\"createdAt\":\"2026-09-01T16:12:33.297Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system (CNS) stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate to severe binge eating disorder (BED). It is a prodrug, meaning it is inactive until metabolized by the body into its active form, dextroamphetamine. This medication contains no nutritional value. It carries a boxed warning for high potential for abuse, misuse, and addiction. Common side effects include decreased appetite, insomnia, dry mouth, and headache. Always follow your healthcare provider's instructions, as this is a controlled substance (Schedule II) and should not be shared or used without a prescription.\",\"gramWeight\":0.06,\"hiddenFromFriends\":true,\"id\":\"9F751DB1-F545-4A66-AD98-48BD2030D348\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"Active ingredient: Lisdexamfetamine dimesylate 60 mg per capsule. Inactive ingredients include microcrystalline cellulose, croscarmellose sodium, and magnesium stearate.\",\"nutrients\":{},\"productReference\":{\"activeComponents\":[{\"molecule\":{\"canonicalSMILES\":\"CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"inchiKey\":\"CETWSOHVEGTIBR-FORAGAHYSA-N\",\"isomericSMILES\":\"C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"iupacName\":\"(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide;methanesulfonic acid\",\"molecularFormula\":\"C17H33N3O7S2\",\"molecularWeight\":\"455.6\",\"pubChemCID\":11597697,\"title\":\"Lisdexamfetamine Dimesylate\"},\"name\":\"Lisdexamfetamine Dimesylate\",\"role\":\"Active ingredient\"}],\"brandName\":\"Vyvanse\",\"categoryLabel\":\"Human Prescription Drug\",\"confidence\":\"officialLabel\",\"displayName\":\"Vyvanse\",\"genericName\":\"Lisdexamfetamine Dimesylate\",\"lookedUpAt\":\"2026-08-06T13:57:53.255Z\",\"otherIngredients\":[\"artificial strawberry flavor\",\"colloidal silicon dioxide\",\"croscarmellose sodium\",\"guar gum\",\"magnesium stearate\",\"mannitol\",\"microcrystalline cellulose\",\"sucralose\"],\"query\":\"Vyvanse\",\"sources\":[{\"name\":\"FDA Structured Product Label\",\"url\":\"https://open.fda.gov/apis/drug/label/\"},{\"name\":\"NIH PubChem — Lisdexamfetamine Dimesylate\",\"url\":\"https://pubchem.ncbi.nlm.nih.gov/compound/11597697\"}],\"summary\":\"Vyvanse is an FDA-labeled product containing Lisdexamfetamine Dimesylate.\"},\"quantityWasUserAdjusted\":false,\"servingSize\":60,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"high\",\"identityEvidence\":\"nutritionLabel\",\"notes\":[\"Supplement label values retained with their product reference.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-09-01T16:12:33.297Z\",\"useCount\":0}",
      "consumed_timestamp": "2026-09-01T16:12:33.297Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-09-02",
      "recorded_timestamp": "2026-09-02T18:44:07.394Z",
      "local_time": "1:44 PM",
      "meal_id": "CED0D975-5314-4E3B-866D-1ECEE500299D",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 60,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":60,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-09-02T18:44:07.394Z\",\"createdAt\":\"2026-09-02T18:44:07.394Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system (CNS) stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate to severe binge eating disorder (BED). It is a prodrug, meaning it is inactive until metabolized by the body into its active form, dextroamphetamine. This medication contains no nutritional value. It carries a boxed warning for high potential for abuse, misuse, and addiction. Common side effects include decreased appetite, insomnia, dry mouth, and headache. Always follow your healthcare provider's instructions, as this is a controlled substance (Schedule II) and should not be shared or used without a prescription.\",\"gramWeight\":0.06,\"hiddenFromFriends\":true,\"id\":\"F4C02622-8E6E-4C7D-93EA-B91FACAEFF66\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"Active ingredient: Lisdexamfetamine dimesylate 60 mg per capsule. Inactive ingredients include microcrystalline cellulose, croscarmellose sodium, and magnesium stearate.\",\"nutrients\":{},\"productReference\":{\"activeComponents\":[{\"molecule\":{\"canonicalSMILES\":\"CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"inchiKey\":\"CETWSOHVEGTIBR-FORAGAHYSA-N\",\"isomericSMILES\":\"C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"iupacName\":\"(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide;methanesulfonic acid\",\"molecularFormula\":\"C17H33N3O7S2\",\"molecularWeight\":\"455.6\",\"pubChemCID\":11597697,\"title\":\"Lisdexamfetamine Dimesylate\"},\"name\":\"Lisdexamfetamine Dimesylate\",\"role\":\"Active ingredient\"}],\"brandName\":\"Vyvanse\",\"categoryLabel\":\"Human Prescription Drug\",\"confidence\":\"officialLabel\",\"displayName\":\"Vyvanse\",\"genericName\":\"Lisdexamfetamine Dimesylate\",\"lookedUpAt\":\"2026-08-06T13:57:53.255Z\",\"otherIngredients\":[\"artificial strawberry flavor\",\"colloidal silicon dioxide\",\"croscarmellose sodium\",\"guar gum\",\"magnesium stearate\",\"mannitol\",\"microcrystalline cellulose\",\"sucralose\"],\"query\":\"Vyvanse\",\"sources\":[{\"name\":\"FDA Structured Product Label\",\"url\":\"https://open.fda.gov/apis/drug/label/\"},{\"name\":\"NIH PubChem — Lisdexamfetamine Dimesylate\",\"url\":\"https://pubchem.ncbi.nlm.nih.gov/compound/11597697\"}],\"summary\":\"Vyvanse is an FDA-labeled product containing Lisdexamfetamine Dimesylate.\"},\"quantityWasUserAdjusted\":false,\"servingSize\":60,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"high\",\"identityEvidence\":\"nutritionLabel\",\"notes\":[\"Supplement label values retained with their product reference.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-09-02T18:44:07.394Z\",\"useCount\":0}",
      "consumed_timestamp": "2026-09-02T18:44:07.394Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-09-03",
      "recorded_timestamp": "2026-09-04T03:08:47.470Z",
      "local_time": "12:08 PM",
      "meal_id": "58A07BAB-2424-45A7-B362-C5C8CD381E75",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 60,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":60,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-09-03T17:08:50.000Z\",\"createdAt\":\"2026-09-04T03:08:47.470Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system (CNS) stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate to severe binge eating disorder (BED). It is a prodrug, meaning it is inactive until metabolized by the body into its active form, dextroamphetamine. This medication contains no nutritional value. It carries a boxed warning for high potential for abuse, misuse, and addiction. Common side effects include decreased appetite, insomnia, dry mouth, and headache. Always follow your healthcare provider's instructions, as this is a controlled substance (Schedule II) and should not be shared or used without a prescription.\",\"gramWeight\":0.06,\"hiddenFromFriends\":true,\"id\":\"7F903B1A-B058-4B70-88F6-57DCFA357A93\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"Active ingredient: Lisdexamfetamine dimesylate 60 mg per capsule. Inactive ingredients include microcrystalline cellulose, croscarmellose sodium, and magnesium stearate.\",\"nutrients\":{},\"productReference\":{\"activeComponents\":[{\"molecule\":{\"canonicalSMILES\":\"CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"inchiKey\":\"CETWSOHVEGTIBR-FORAGAHYSA-N\",\"isomericSMILES\":\"C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"iupacName\":\"(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide;methanesulfonic acid\",\"molecularFormula\":\"C17H33N3O7S2\",\"molecularWeight\":\"455.6\",\"pubChemCID\":11597697,\"title\":\"Lisdexamfetamine Dimesylate\"},\"name\":\"Lisdexamfetamine Dimesylate\",\"role\":\"Active ingredient\"}],\"brandName\":\"Vyvanse\",\"categoryLabel\":\"Human Prescription Drug\",\"confidence\":\"officialLabel\",\"displayName\":\"Vyvanse\",\"genericName\":\"Lisdexamfetamine Dimesylate\",\"lookedUpAt\":\"2026-08-06T13:57:53.255Z\",\"otherIngredients\":[\"artificial strawberry flavor\",\"colloidal silicon dioxide\",\"croscarmellose sodium\",\"guar gum\",\"magnesium stearate\",\"mannitol\",\"microcrystalline cellulose\",\"sucralose\"],\"query\":\"Vyvanse\",\"sources\":[{\"name\":\"FDA Structured Product Label\",\"url\":\"https://open.fda.gov/apis/drug/label/\"},{\"name\":\"NIH PubChem — Lisdexamfetamine Dimesylate\",\"url\":\"https://pubchem.ncbi.nlm.nih.gov/compound/11597697\"}],\"summary\":\"Vyvanse is an FDA-labeled product containing Lisdexamfetamine Dimesylate.\"},\"quantityWasUserAdjusted\":false,\"servingSize\":60,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"high\",\"identityEvidence\":\"nutritionLabel\",\"notes\":[\"Supplement label values retained with their product reference.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-09-04T03:08:59.905Z\",\"useCount\":0}",
      "consumed_timestamp": "2026-09-03T17:08:50.000Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-09-04",
      "recorded_timestamp": "2026-09-05T04:45:41.582Z",
      "local_time": "11:45 AM",
      "meal_id": "9809E5F4-EC53-45B0-BF85-6098D7501BDE",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 60,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":60,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-09-04T16:45:41.000Z\",\"createdAt\":\"2026-09-05T04:45:41.582Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system (CNS) stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate to severe binge eating disorder (BED). It is a prodrug, meaning it is inactive until metabolized by the body into its active form, dextroamphetamine. This medication contains no nutritional value. It carries a boxed warning for high potential for abuse, misuse, and addiction. Common side effects include decreased appetite, insomnia, dry mouth, and headache. Always follow your healthcare provider's instructions, as this is a controlled substance (Schedule II) and should not be shared or used without a prescription.\",\"gramWeight\":0.06,\"hiddenFromFriends\":true,\"id\":\"C7163291-BC8D-4279-9CDF-B1B019C2ACA2\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"Active ingredient: Lisdexamfetamine dimesylate 60 mg per capsule. Inactive ingredients include microcrystalline cellulose, croscarmellose sodium, and magnesium stearate.\",\"nutrients\":{},\"productReference\":{\"activeComponents\":[{\"molecule\":{\"canonicalSMILES\":\"CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"inchiKey\":\"CETWSOHVEGTIBR-FORAGAHYSA-N\",\"isomericSMILES\":\"C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"iupacName\":\"(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide;methanesulfonic acid\",\"molecularFormula\":\"C17H33N3O7S2\",\"molecularWeight\":\"455.6\",\"pubChemCID\":11597697,\"title\":\"Lisdexamfetamine Dimesylate\"},\"name\":\"Lisdexamfetamine Dimesylate\",\"role\":\"Active ingredient\"}],\"brandName\":\"Vyvanse\",\"categoryLabel\":\"Human Prescription Drug\",\"confidence\":\"officialLabel\",\"displayName\":\"Vyvanse\",\"genericName\":\"Lisdexamfetamine Dimesylate\",\"lookedUpAt\":\"2026-08-06T13:57:53.255Z\",\"otherIngredients\":[\"artificial strawberry flavor\",\"colloidal silicon dioxide\",\"croscarmellose sodium\",\"guar gum\",\"magnesium stearate\",\"mannitol\",\"microcrystalline cellulose\",\"sucralose\"],\"query\":\"Vyvanse\",\"sources\":[{\"name\":\"FDA Structured Product Label\",\"url\":\"https://open.fda.gov/apis/drug/label/\"},{\"name\":\"NIH PubChem — Lisdexamfetamine Dimesylate\",\"url\":\"https://pubchem.ncbi.nlm.nih.gov/compound/11597697\"}],\"summary\":\"Vyvanse is an FDA-labeled product containing Lisdexamfetamine Dimesylate.\"},\"quantityWasUserAdjusted\":false,\"servingSize\":60,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"high\",\"identityEvidence\":\"nutritionLabel\",\"notes\":[\"Supplement label values retained with their product reference.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-09-05T04:45:46.262Z\",\"useCount\":0}",
      "consumed_timestamp": "2026-09-04T16:45:41.000Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-09-05",
      "recorded_timestamp": "2026-09-05T17:57:05.135Z",
      "local_time": "12:10 PM",
      "meal_id": "49AA3225-104B-4763-B5BB-8A3DFDA4BE07",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 60,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":60,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-09-05T17:10:05.000Z\",\"createdAt\":\"2026-09-05T17:57:05.135Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system (CNS) stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate to severe binge eating disorder (BED). It is a prodrug, meaning it is inactive until metabolized by the body into its active form, dextroamphetamine. This medication contains no nutritional value. It carries a boxed warning for high potential for abuse, misuse, and addiction. Common side effects include decreased appetite, insomnia, dry mouth, and headache. Always follow your healthcare provider's instructions, as this is a controlled substance (Schedule II) and should not be shared or used without a prescription.\",\"gramWeight\":0.06,\"hiddenFromFriends\":true,\"id\":\"897987D9-5C6A-4C09-9887-5D5188282C44\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"Active ingredient: Lisdexamfetamine dimesylate 60 mg per capsule. Inactive ingredients include microcrystalline cellulose, croscarmellose sodium, and magnesium stearate.\",\"nutrients\":{},\"productReference\":{\"activeComponents\":[{\"molecule\":{\"canonicalSMILES\":\"CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"inchiKey\":\"CETWSOHVEGTIBR-FORAGAHYSA-N\",\"isomericSMILES\":\"C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"iupacName\":\"(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide;methanesulfonic acid\",\"molecularFormula\":\"C17H33N3O7S2\",\"molecularWeight\":\"455.6\",\"pubChemCID\":11597697,\"title\":\"Lisdexamfetamine Dimesylate\"},\"name\":\"Lisdexamfetamine Dimesylate\",\"role\":\"Active ingredient\"}],\"brandName\":\"Vyvanse\",\"categoryLabel\":\"Human Prescription Drug\",\"confidence\":\"officialLabel\",\"displayName\":\"Vyvanse\",\"genericName\":\"Lisdexamfetamine Dimesylate\",\"lookedUpAt\":\"2026-08-06T13:57:53.255Z\",\"otherIngredients\":[\"artificial strawberry flavor\",\"colloidal silicon dioxide\",\"croscarmellose sodium\",\"guar gum\",\"magnesium stearate\",\"mannitol\",\"microcrystalline cellulose\",\"sucralose\"],\"query\":\"Vyvanse\",\"sources\":[{\"name\":\"FDA Structured Product Label\",\"url\":\"https://open.fda.gov/apis/drug/label/\"},{\"name\":\"NIH PubChem — Lisdexamfetamine Dimesylate\",\"url\":\"https://pubchem.ncbi.nlm.nih.gov/compound/11597697\"}],\"summary\":\"Vyvanse is an FDA-labeled product containing Lisdexamfetamine Dimesylate.\"},\"quantityWasUserAdjusted\":false,\"servingSize\":60,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"high\",\"identityEvidence\":\"nutritionLabel\",\"notes\":[\"Supplement label values retained with their product reference.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-09-05T17:57:14.475Z\",\"useCount\":0}",
      "consumed_timestamp": "2026-09-05T17:10:05.000Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-09-06",
      "recorded_timestamp": "2026-09-06T23:26:27.980Z",
      "local_time": "6:26 PM",
      "meal_id": "2AA383A9-6C3E-49CD-B3B0-44649661220F",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 20,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":20,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-09-06T23:26:27.980Z\",\"createdAt\":\"2026-09-06T23:26:27.980Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a central nervous system stimulant used primarily to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate to severe Binge Eating Disorder (BED). The active ingredient is lisdexamfetamine dimesylate 20 mg, which is a prodrug that is converted in the body to dextroamphetamine (the active stimulant). This medication contains no nutritional value. Important safety note: This is a controlled substance with a potential for abuse and dependence. It may cause side effects such as increased heart rate, elevated blood pressure, insomnia, and decreased appetite. Do not combine with other stimulants or MAO inhibitors without medical supervision. Not Google-sourced; model-only estimate.\",\"gramWeight\":0.02,\"hiddenFromFriends\":true,\"id\":\"9D9B75F7-050D-4763-913C-F7EEB9BD9D2B\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"Lisdexamfetamine dimesylate 20 mg\",\"nutrients\":{},\"nutritionEvidence\":[{\"basis\":\"perServing\",\"citation\":\"Model-estimated serving amount; not confirmed by the user\",\"estimatedErrorPct\":30,\"id\":\"model-assumed-serving\",\"identityConfidence\":1,\"retrievedAt\":\"2026-09-06T23:26:18.543Z\",\"reusePolicy\":\"allowed\",\"source\":\"aiSearch\",\"sourceID\":\"gemini-3.1-flash-lite\",\"sourcePolicyID\":\"google-ai-generated-output-v1\",\"valueConfidence\":1},{\"basis\":\"userProvided\",\"citation\":\"Dose entered by the user\",\"id\":\"user-recorded-dose\",\"identityConfidence\":3,\"retrievedAt\":\"2026-09-06T23:26:18.544Z\",\"reusePolicy\":\"allowed\",\"source\":\"userEntered\",\"sourcePolicyID\":\"user-provided-entry-v1\",\"valueConfidence\":3}],\"nutritionSearchTrace\":{\"methodologyVersion\":\"nutrition-evidence-v1\",\"normalizedQuery\":\"vyvanse\",\"nutritionWasModelGenerated\":false,\"steps\":[{\"confidence\":1,\"detail\":\"Retained the model-estimated serving as an unconfirmed logging amount.\",\"evidenceID\":\"model-assumed-serving\",\"kind\":\"candidateResolution\",\"sourceID\":\"gemini-3.1-flash-lite\"}]},\"productReference\":{\"activeComponents\":[{\"molecule\":{\"canonicalSMILES\":\"CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"inchiKey\":\"CETWSOHVEGTIBR-FORAGAHYSA-N\",\"isomericSMILES\":\"C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"iupacName\":\"(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide;methanesulfonic acid\",\"molecularFormula\":\"C17H33N3O7S2\",\"molecularWeight\":\"455.6\",\"pubChemCID\":11597697,\"title\":\"Lisdexamfetamine Dimesylate\"},\"name\":\"Lisdexamfetamine Dimesylate\",\"role\":\"Active ingredient\"}],\"brandName\":\"Vyvanse\",\"categoryLabel\":\"Human Prescription Drug\",\"confidence\":\"officialLabel\",\"displayName\":\"Vyvanse\",\"genericName\":\"Lisdexamfetamine Dimesylate\",\"lookedUpAt\":\"2026-09-06T23:26:17.993Z\",\"otherIngredients\":[\"artificial strawberry flavor\",\"colloidal silicon dioxide\",\"croscarmellose sodium\",\"guar gum\",\"magnesium stearate\",\"mannitol\",\"microcrystalline cellulose\",\"sucralose\"],\"query\":\"Vyvanse\",\"sources\":[{\"name\":\"FDA Structured Product Label\",\"url\":\"https://open.fda.gov/apis/drug/label/\"},{\"name\":\"NIH PubChem — Lisdexamfetamine Dimesylate\",\"url\":\"https://pubchem.ncbi.nlm.nih.gov/compound/11597697\"}],\"summary\":\"Vyvanse is an FDA-labeled product containing Lisdexamfetamine Dimesylate.\"},\"quantityEvidenceID\":\"user-recorded-dose\",\"quantityWasUserAdjusted\":false,\"servingSize\":20,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"high\",\"identityEvidence\":\"nutritionLabel\",\"notes\":[\"Supplement label values retained with their product reference.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-09-06T23:26:27.980Z\",\"useCount\":0}",
      "consumed_timestamp": "2026-09-06T23:26:27.980Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-09-07",
      "recorded_timestamp": "2026-09-07T18:57:15.457Z",
      "local_time": "12:57 PM",
      "meal_id": "E74F7DD9-1F40-4FCB-A386-96A2674B70B7",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 20,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":20,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-09-07T17:57:15.000Z\",\"createdAt\":\"2026-09-07T18:57:15.457Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a central nervous system stimulant used primarily to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate to severe Binge Eating Disorder (BED). The active ingredient is lisdexamfetamine dimesylate 20 mg, which is a prodrug that is converted in the body to dextroamphetamine (the active stimulant). This medication contains no nutritional value. Important safety note: This is a controlled substance with a potential for abuse and dependence. It may cause side effects such as increased heart rate, elevated blood pressure, insomnia, and decreased appetite. Do not combine with other stimulants or MAO inhibitors without medical supervision. Not Google-sourced; model-only estimate.\",\"gramWeight\":0.02,\"hiddenFromFriends\":true,\"id\":\"B10F87B1-8694-4206-B532-35F0694A2FB4\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"Lisdexamfetamine dimesylate 20 mg\",\"nutrients\":{},\"nutritionEvidence\":[{\"basis\":\"perServing\",\"citation\":\"Model-estimated serving amount; not confirmed by the user\",\"estimatedErrorPct\":30,\"id\":\"model-assumed-serving\",\"identityConfidence\":1,\"retrievedAt\":\"2026-09-06T23:26:18.543Z\",\"reusePolicy\":\"allowed\",\"source\":\"aiSearch\",\"sourceID\":\"gemini-3.1-flash-lite\",\"sourcePolicyID\":\"google-ai-generated-output-v1\",\"valueConfidence\":1},{\"basis\":\"userProvided\",\"citation\":\"Dose entered by the user\",\"id\":\"user-recorded-dose\",\"identityConfidence\":3,\"retrievedAt\":\"2026-09-06T23:26:18.544Z\",\"reusePolicy\":\"allowed\",\"source\":\"userEntered\",\"sourcePolicyID\":\"user-provided-entry-v1\",\"valueConfidence\":3}],\"nutritionSearchTrace\":{\"methodologyVersion\":\"nutrition-evidence-v1\",\"normalizedQuery\":\"vyvanse\",\"nutritionWasModelGenerated\":false,\"steps\":[{\"confidence\":1,\"detail\":\"Retained the model-estimated serving as an unconfirmed logging amount.\",\"evidenceID\":\"model-assumed-serving\",\"kind\":\"candidateResolution\",\"sourceID\":\"gemini-3.1-flash-lite\"}]},\"productReference\":{\"activeComponents\":[{\"molecule\":{\"canonicalSMILES\":\"CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"inchiKey\":\"CETWSOHVEGTIBR-FORAGAHYSA-N\",\"isomericSMILES\":\"C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"iupacName\":\"(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide;methanesulfonic acid\",\"molecularFormula\":\"C17H33N3O7S2\",\"molecularWeight\":\"455.6\",\"pubChemCID\":11597697,\"title\":\"Lisdexamfetamine Dimesylate\"},\"name\":\"Lisdexamfetamine Dimesylate\",\"role\":\"Active ingredient\"}],\"brandName\":\"Vyvanse\",\"categoryLabel\":\"Human Prescription Drug\",\"confidence\":\"officialLabel\",\"displayName\":\"Vyvanse\",\"genericName\":\"Lisdexamfetamine Dimesylate\",\"lookedUpAt\":\"2026-09-06T23:26:17.993Z\",\"otherIngredients\":[\"artificial strawberry flavor\",\"colloidal silicon dioxide\",\"croscarmellose sodium\",\"guar gum\",\"magnesium stearate\",\"mannitol\",\"microcrystalline cellulose\",\"sucralose\"],\"query\":\"Vyvanse\",\"sources\":[{\"name\":\"FDA Structured Product Label\",\"url\":\"https://open.fda.gov/apis/drug/label/\"},{\"name\":\"NIH PubChem — Lisdexamfetamine Dimesylate\",\"url\":\"https://pubchem.ncbi.nlm.nih.gov/compound/11597697\"}],\"summary\":\"Vyvanse is an FDA-labeled product containing Lisdexamfetamine Dimesylate.\"},\"quantityEvidenceID\":\"user-recorded-dose\",\"quantityWasUserAdjusted\":false,\"servingSize\":20,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"high\",\"identityEvidence\":\"nutritionLabel\",\"notes\":[\"Supplement label values retained with their product reference.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-09-07T18:57:23.106Z\",\"useCount\":0}",
      "consumed_timestamp": "2026-09-07T17:57:15.000Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-09-08",
      "recorded_timestamp": "2026-09-08T19:42:23.383Z",
      "local_time": "2:42 PM",
      "meal_id": "7B40142E-7F2C-4EE1-A953-C2153788F291",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 20,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":20,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-09-08T19:42:23.383Z\",\"createdAt\":\"2026-09-08T19:42:23.383Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a central nervous system stimulant used primarily to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate to severe Binge Eating Disorder (BED). The active ingredient is lisdexamfetamine dimesylate 20 mg, which is a prodrug that is converted in the body to dextroamphetamine (the active stimulant). This medication contains no nutritional value. Important safety note: This is a controlled substance with a potential for abuse and dependence. It may cause side effects such as increased heart rate, elevated blood pressure, insomnia, and decreased appetite. Do not combine with other stimulants or MAO inhibitors without medical supervision. Not Google-sourced; model-only estimate.\",\"gramWeight\":0.02,\"hiddenFromFriends\":true,\"id\":\"F45BC90B-20B7-4EFB-A7C7-34A7CD9E097D\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"Lisdexamfetamine dimesylate 20 mg\",\"nutrients\":{},\"nutritionEvidence\":[{\"basis\":\"perServing\",\"citation\":\"Model-estimated serving amount; not confirmed by the user\",\"estimatedErrorPct\":30,\"id\":\"model-assumed-serving\",\"identityConfidence\":1,\"retrievedAt\":\"2026-09-06T23:26:18.543Z\",\"reusePolicy\":\"allowed\",\"source\":\"aiSearch\",\"sourceID\":\"gemini-3.1-flash-lite\",\"sourcePolicyID\":\"google-ai-generated-output-v1\",\"valueConfidence\":1},{\"basis\":\"userProvided\",\"citation\":\"Dose entered by the user\",\"id\":\"user-recorded-dose\",\"identityConfidence\":3,\"retrievedAt\":\"2026-09-06T23:26:18.544Z\",\"reusePolicy\":\"allowed\",\"source\":\"userEntered\",\"sourcePolicyID\":\"user-provided-entry-v1\",\"valueConfidence\":3}],\"nutritionSearchTrace\":{\"methodologyVersion\":\"nutrition-evidence-v1\",\"normalizedQuery\":\"vyvanse\",\"nutritionWasModelGenerated\":false,\"steps\":[{\"confidence\":1,\"detail\":\"Retained the model-estimated serving as an unconfirmed logging amount.\",\"evidenceID\":\"model-assumed-serving\",\"kind\":\"candidateResolution\",\"sourceID\":\"gemini-3.1-flash-lite\"}]},\"productReference\":{\"activeComponents\":[{\"molecule\":{\"canonicalSMILES\":\"CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"inchiKey\":\"CETWSOHVEGTIBR-FORAGAHYSA-N\",\"isomericSMILES\":\"C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"iupacName\":\"(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide;methanesulfonic acid\",\"molecularFormula\":\"C17H33N3O7S2\",\"molecularWeight\":\"455.6\",\"pubChemCID\":11597697,\"title\":\"Lisdexamfetamine Dimesylate\"},\"name\":\"Lisdexamfetamine Dimesylate\",\"role\":\"Active ingredient\"}],\"brandName\":\"Vyvanse\",\"categoryLabel\":\"Human Prescription Drug\",\"confidence\":\"officialLabel\",\"displayName\":\"Vyvanse\",\"genericName\":\"Lisdexamfetamine Dimesylate\",\"lookedUpAt\":\"2026-09-06T23:26:17.993Z\",\"otherIngredients\":[\"artificial strawberry flavor\",\"colloidal silicon dioxide\",\"croscarmellose sodium\",\"guar gum\",\"magnesium stearate\",\"mannitol\",\"microcrystalline cellulose\",\"sucralose\"],\"query\":\"Vyvanse\",\"sources\":[{\"name\":\"FDA Structured Product Label\",\"url\":\"https://open.fda.gov/apis/drug/label/\"},{\"name\":\"NIH PubChem — Lisdexamfetamine Dimesylate\",\"url\":\"https://pubchem.ncbi.nlm.nih.gov/compound/11597697\"}],\"summary\":\"Vyvanse is an FDA-labeled product containing Lisdexamfetamine Dimesylate.\"},\"quantityEvidenceID\":\"user-recorded-dose\",\"quantityWasUserAdjusted\":false,\"servingSize\":20,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"high\",\"identityEvidence\":\"nutritionLabel\",\"notes\":[\"Supplement label values retained with their product reference.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-09-08T19:42:23.383Z\",\"useCount\":0}",
      "consumed_timestamp": "2026-09-08T19:42:23.383Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-09-09",
      "recorded_timestamp": "2026-09-09T18:25:47.904Z",
      "local_time": "1:25 PM",
      "meal_id": "3489EBD0-AE92-4AC0-9D7F-C11BC59B3480",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 20,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":20,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-09-09T18:25:47.904Z\",\"createdAt\":\"2026-09-09T18:25:47.904Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a central nervous system stimulant used primarily to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate to severe Binge Eating Disorder (BED). The active ingredient is lisdexamfetamine dimesylate 20 mg, which is a prodrug that is converted in the body to dextroamphetamine (the active stimulant). This medication contains no nutritional value. Important safety note: This is a controlled substance with a potential for abuse and dependence. It may cause side effects such as increased heart rate, elevated blood pressure, insomnia, and decreased appetite. Do not combine with other stimulants or MAO inhibitors without medical supervision. Not Google-sourced; model-only estimate.\",\"gramWeight\":0.02,\"hiddenFromFriends\":true,\"id\":\"653A95D4-084F-4A35-9B57-980CC701E8BA\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"Lisdexamfetamine dimesylate 20 mg\",\"nutrients\":{},\"nutritionEvidence\":[{\"basis\":\"perServing\",\"citation\":\"Model-estimated serving amount; not confirmed by the user\",\"estimatedErrorPct\":30,\"id\":\"model-assumed-serving\",\"identityConfidence\":1,\"retrievedAt\":\"2026-09-06T23:26:18.543Z\",\"reusePolicy\":\"allowed\",\"source\":\"aiSearch\",\"sourceID\":\"gemini-3.1-flash-lite\",\"sourcePolicyID\":\"google-ai-generated-output-v1\",\"valueConfidence\":1},{\"basis\":\"userProvided\",\"citation\":\"Dose entered by the user\",\"id\":\"user-recorded-dose\",\"identityConfidence\":3,\"retrievedAt\":\"2026-09-06T23:26:18.544Z\",\"reusePolicy\":\"allowed\",\"source\":\"userEntered\",\"sourcePolicyID\":\"user-provided-entry-v1\",\"valueConfidence\":3}],\"nutritionSearchTrace\":{\"methodologyVersion\":\"nutrition-evidence-v1\",\"normalizedQuery\":\"vyvanse\",\"nutritionWasModelGenerated\":false,\"steps\":[{\"confidence\":1,\"detail\":\"Retained the model-estimated serving as an unconfirmed logging amount.\",\"evidenceID\":\"model-assumed-serving\",\"kind\":\"candidateResolution\",\"sourceID\":\"gemini-3.1-flash-lite\"}]},\"productReference\":{\"activeComponents\":[{\"molecule\":{\"canonicalSMILES\":\"CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"inchiKey\":\"CETWSOHVEGTIBR-FORAGAHYSA-N\",\"isomericSMILES\":\"C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"iupacName\":\"(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide;methanesulfonic acid\",\"molecularFormula\":\"C17H33N3O7S2\",\"molecularWeight\":\"455.6\",\"pubChemCID\":11597697,\"title\":\"Lisdexamfetamine Dimesylate\"},\"name\":\"Lisdexamfetamine Dimesylate\",\"role\":\"Active ingredient\"}],\"brandName\":\"Vyvanse\",\"categoryLabel\":\"Human Prescription Drug\",\"confidence\":\"officialLabel\",\"displayName\":\"Vyvanse\",\"genericName\":\"Lisdexamfetamine Dimesylate\",\"lookedUpAt\":\"2026-09-06T23:26:17.993Z\",\"otherIngredients\":[\"artificial strawberry flavor\",\"colloidal silicon dioxide\",\"croscarmellose sodium\",\"guar gum\",\"magnesium stearate\",\"mannitol\",\"microcrystalline cellulose\",\"sucralose\"],\"query\":\"Vyvanse\",\"sources\":[{\"name\":\"FDA Structured Product Label\",\"url\":\"https://open.fda.gov/apis/drug/label/\"},{\"name\":\"NIH PubChem — Lisdexamfetamine Dimesylate\",\"url\":\"https://pubchem.ncbi.nlm.nih.gov/compound/11597697\"}],\"summary\":\"Vyvanse is an FDA-labeled product containing Lisdexamfetamine Dimesylate.\"},\"quantityEvidenceID\":\"user-recorded-dose\",\"quantityWasUserAdjusted\":false,\"servingSize\":20,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"high\",\"identityEvidence\":\"nutritionLabel\",\"notes\":[\"Supplement label values retained with their product reference.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-09-09T18:25:47.904Z\",\"useCount\":0}",
      "consumed_timestamp": "2026-09-09T18:25:47.904Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-09-10",
      "recorded_timestamp": "2026-09-10T19:23:02.796Z",
      "local_time": "2:23 PM",
      "meal_id": "4AACECE9-EFEC-45E5-80AC-5ABA50BFEB9F",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 20,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":20,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-09-10T19:23:02.796Z\",\"createdAt\":\"2026-09-10T19:23:02.796Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a central nervous system stimulant used primarily to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate to severe Binge Eating Disorder (BED). The active ingredient is lisdexamfetamine dimesylate 20 mg, which is a prodrug that is converted in the body to dextroamphetamine (the active stimulant). This medication contains no nutritional value. Important safety note: This is a controlled substance with a potential for abuse and dependence. It may cause side effects such as increased heart rate, elevated blood pressure, insomnia, and decreased appetite. Do not combine with other stimulants or MAO inhibitors without medical supervision. Not Google-sourced; model-only estimate.\",\"gramWeight\":0.02,\"hiddenFromFriends\":true,\"id\":\"06778342-D992-430D-9E37-37D25BB43948\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"Lisdexamfetamine dimesylate 20 mg\",\"nutrients\":{},\"nutritionEvidence\":[{\"basis\":\"perServing\",\"citation\":\"Model-estimated serving amount; not confirmed by the user\",\"estimatedErrorPct\":30,\"id\":\"model-assumed-serving\",\"identityConfidence\":1,\"retrievedAt\":\"2026-09-06T23:26:18.543Z\",\"reusePolicy\":\"allowed\",\"source\":\"aiSearch\",\"sourceID\":\"gemini-3.1-flash-lite\",\"sourcePolicyID\":\"google-ai-generated-output-v1\",\"valueConfidence\":1},{\"basis\":\"userProvided\",\"citation\":\"Dose entered by the user\",\"id\":\"user-recorded-dose\",\"identityConfidence\":3,\"retrievedAt\":\"2026-09-06T23:26:18.544Z\",\"reusePolicy\":\"allowed\",\"source\":\"userEntered\",\"sourcePolicyID\":\"user-provided-entry-v1\",\"valueConfidence\":3}],\"nutritionSearchTrace\":{\"methodologyVersion\":\"nutrition-evidence-v1\",\"normalizedQuery\":\"vyvanse\",\"nutritionWasModelGenerated\":false,\"steps\":[{\"confidence\":1,\"detail\":\"Retained the model-estimated serving as an unconfirmed logging amount.\",\"evidenceID\":\"model-assumed-serving\",\"kind\":\"candidateResolution\",\"sourceID\":\"gemini-3.1-flash-lite\"}]},\"productReference\":{\"activeComponents\":[{\"molecule\":{\"canonicalSMILES\":\"CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"inchiKey\":\"CETWSOHVEGTIBR-FORAGAHYSA-N\",\"isomericSMILES\":\"C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"iupacName\":\"(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide;methanesulfonic acid\",\"molecularFormula\":\"C17H33N3O7S2\",\"molecularWeight\":\"455.6\",\"pubChemCID\":11597697,\"title\":\"Lisdexamfetamine Dimesylate\"},\"name\":\"Lisdexamfetamine Dimesylate\",\"role\":\"Active ingredient\"}],\"brandName\":\"Vyvanse\",\"categoryLabel\":\"Human Prescription Drug\",\"confidence\":\"officialLabel\",\"displayName\":\"Vyvanse\",\"genericName\":\"Lisdexamfetamine Dimesylate\",\"lookedUpAt\":\"2026-09-06T23:26:17.993Z\",\"otherIngredients\":[\"artificial strawberry flavor\",\"colloidal silicon dioxide\",\"croscarmellose sodium\",\"guar gum\",\"magnesium stearate\",\"mannitol\",\"microcrystalline cellulose\",\"sucralose\"],\"query\":\"Vyvanse\",\"sources\":[{\"name\":\"FDA Structured Product Label\",\"url\":\"https://open.fda.gov/apis/drug/label/\"},{\"name\":\"NIH PubChem — Lisdexamfetamine Dimesylate\",\"url\":\"https://pubchem.ncbi.nlm.nih.gov/compound/11597697\"}],\"summary\":\"Vyvanse is an FDA-labeled product containing Lisdexamfetamine Dimesylate.\"},\"quantityEvidenceID\":\"user-recorded-dose\",\"quantityWasUserAdjusted\":false,\"servingSize\":20,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"high\",\"identityEvidence\":\"nutritionLabel\",\"notes\":[\"Supplement label values retained with their product reference.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-09-10T19:23:02.796Z\",\"useCount\":0}",
      "consumed_timestamp": "2026-09-10T19:23:02.796Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-09-11",
      "recorded_timestamp": "2026-09-11T18:11:09.282Z",
      "local_time": "1:11 PM",
      "meal_id": "F41B1D81-E6AC-48B0-8337-96AE58D61AE3",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 20,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":20,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-09-11T18:11:09.282Z\",\"createdAt\":\"2026-09-11T18:11:09.282Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a central nervous system stimulant used primarily to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate to severe Binge Eating Disorder (BED). The active ingredient is lisdexamfetamine dimesylate 20 mg, which is a prodrug that is converted in the body to dextroamphetamine (the active stimulant). This medication contains no nutritional value. Important safety note: This is a controlled substance with a potential for abuse and dependence. It may cause side effects such as increased heart rate, elevated blood pressure, insomnia, and decreased appetite. Do not combine with other stimulants or MAO inhibitors without medical supervision. Not Google-sourced; model-only estimate.\",\"gramWeight\":0.02,\"hiddenFromFriends\":true,\"householdUnitGramWeights\":{\"mg\":0.001},\"id\":\"BFC9555A-B7AB-4290-BAD6-BA765538E6F6\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"Lisdexamfetamine dimesylate 20 mg\",\"nutrients\":{},\"nutritionEvidence\":[{\"basis\":\"perServing\",\"citation\":\"Model-estimated serving amount; not confirmed by the user\",\"estimatedErrorPct\":30,\"id\":\"model-assumed-serving\",\"identityConfidence\":1,\"retrievedAt\":\"2026-09-06T23:26:18.543Z\",\"reusePolicy\":\"allowed\",\"source\":\"aiSearch\",\"sourceID\":\"gemini-3.1-flash-lite\",\"sourcePolicyID\":\"google-ai-generated-output-v1\",\"valueConfidence\":1},{\"basis\":\"userProvided\",\"citation\":\"Dose entered by the user\",\"id\":\"user-recorded-dose\",\"identityConfidence\":3,\"retrievedAt\":\"2026-09-06T23:26:18.544Z\",\"reusePolicy\":\"allowed\",\"source\":\"userEntered\",\"sourcePolicyID\":\"user-provided-entry-v1\",\"valueConfidence\":3}],\"nutritionSearchTrace\":{\"methodologyVersion\":\"nutrition-evidence-v1\",\"normalizedQuery\":\"vyvanse\",\"nutritionWasModelGenerated\":false,\"steps\":[{\"confidence\":1,\"detail\":\"Retained the model-estimated serving as an unconfirmed logging amount.\",\"evidenceID\":\"model-assumed-serving\",\"kind\":\"candidateResolution\",\"sourceID\":\"gemini-3.1-flash-lite\"}]},\"productReference\":{\"activeComponents\":[{\"molecule\":{\"canonicalSMILES\":\"CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"inchiKey\":\"CETWSOHVEGTIBR-FORAGAHYSA-N\",\"isomericSMILES\":\"C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"iupacName\":\"(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide;methanesulfonic acid\",\"molecularFormula\":\"C17H33N3O7S2\",\"molecularWeight\":\"455.6\",\"pubChemCID\":11597697,\"title\":\"Lisdexamfetamine Dimesylate\"},\"name\":\"Lisdexamfetamine Dimesylate\",\"role\":\"Active ingredient\"}],\"brandName\":\"Vyvanse\",\"categoryLabel\":\"Human Prescription Drug\",\"confidence\":\"officialLabel\",\"displayName\":\"Vyvanse\",\"genericName\":\"Lisdexamfetamine Dimesylate\",\"lookedUpAt\":\"2026-09-06T23:26:17.993Z\",\"otherIngredients\":[\"artificial strawberry flavor\",\"colloidal silicon dioxide\",\"croscarmellose sodium\",\"guar gum\",\"magnesium stearate\",\"mannitol\",\"microcrystalline cellulose\",\"sucralose\"],\"query\":\"Vyvanse\",\"sources\":[{\"name\":\"FDA Structured Product Label\",\"url\":\"https://open.fda.gov/apis/drug/label/\"},{\"name\":\"NIH PubChem — Lisdexamfetamine Dimesylate\",\"url\":\"https://pubchem.ncbi.nlm.nih.gov/compound/11597697\"}],\"summary\":\"Vyvanse is an FDA-labeled product containing Lisdexamfetamine Dimesylate.\"},\"quantityEvidenceID\":\"user-recorded-dose\",\"quantityWasUserAdjusted\":false,\"servingSize\":20,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"high\",\"identityEvidence\":\"nutritionLabel\",\"notes\":[\"Supplement label values retained with their product reference.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-09-11T18:11:09.282Z\",\"useCount\":0}",
      "consumed_timestamp": "2026-09-11T18:11:09.282Z",
      "timestamp_source": "item.consumedAt"
    },
    {
      "day": "2026-09-12",
      "recorded_timestamp": "2026-09-12T19:44:14.372Z",
      "local_time": "1:44 PM",
      "meal_id": "90AFD278-1ABA-4D91-8544-7D3ED3680C0A",
      "item_index": 0,
      "item_name": "Vyvanse",
      "recorded_dose_mg": 20,
      "recorded_unit": "mg",
      "meal_name": "Medications",
      "raw_item_json": "{\"baseNutrients\":{},\"baseServingSize\":20,\"baseServingUnit\":\"mg\",\"brand\":\"Vyvanse\",\"consumedAt\":\"2026-09-12T18:44:14.000Z\",\"createdAt\":\"2026-09-12T19:44:14.372Z\",\"dailyTimeBucket\":\"morning\",\"geminiExplanation\":\"Vyvanse (lisdexamfetamine dimesylate) is a central nervous system stimulant used primarily to treat Attention Deficit Hyperactivity Disorder (ADHD) and moderate to severe Binge Eating Disorder (BED). The active ingredient is lisdexamfetamine dimesylate 20 mg, which is a prodrug that is converted in the body to dextroamphetamine (the active stimulant). This medication contains no nutritional value. Important safety note: This is a controlled substance with a potential for abuse and dependence. It may cause side effects such as increased heart rate, elevated blood pressure, insomnia, and decreased appetite. Do not combine with other stimulants or MAO inhibitors without medical supervision. Not Google-sourced; model-only estimate.\",\"gramWeight\":0.02,\"hiddenFromFriends\":true,\"householdUnitGramWeights\":{\"mg\":0.001},\"id\":\"19B7258A-1275-4AE5-BE7D-7CBD04061341\",\"isFavorite\":false,\"itemCategory\":\"medication\",\"name\":\"Vyvanse\",\"notes\":\"Lisdexamfetamine dimesylate 20 mg\",\"nutrients\":{},\"nutritionEvidence\":[{\"basis\":\"perServing\",\"citation\":\"Model-estimated serving amount; not confirmed by the user\",\"estimatedErrorPct\":30,\"id\":\"model-assumed-serving\",\"identityConfidence\":1,\"retrievedAt\":\"2026-09-06T23:26:18.543Z\",\"reusePolicy\":\"allowed\",\"source\":\"aiSearch\",\"sourceID\":\"gemini-3.1-flash-lite\",\"sourcePolicyID\":\"google-ai-generated-output-v1\",\"valueConfidence\":1},{\"basis\":\"userProvided\",\"citation\":\"Dose entered by the user\",\"id\":\"user-recorded-dose\",\"identityConfidence\":3,\"retrievedAt\":\"2026-09-06T23:26:18.544Z\",\"reusePolicy\":\"allowed\",\"source\":\"userEntered\",\"sourcePolicyID\":\"user-provided-entry-v1\",\"valueConfidence\":3}],\"nutritionSearchTrace\":{\"methodologyVersion\":\"nutrition-evidence-v1\",\"normalizedQuery\":\"vyvanse\",\"nutritionWasModelGenerated\":false,\"steps\":[{\"confidence\":1,\"detail\":\"Retained the model-estimated serving as an unconfirmed logging amount.\",\"evidenceID\":\"model-assumed-serving\",\"kind\":\"candidateResolution\",\"sourceID\":\"gemini-3.1-flash-lite\"}]},\"productReference\":{\"activeComponents\":[{\"molecule\":{\"canonicalSMILES\":\"CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"inchiKey\":\"CETWSOHVEGTIBR-FORAGAHYSA-N\",\"isomericSMILES\":\"C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O\",\"iupacName\":\"(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide;methanesulfonic acid\",\"molecularFormula\":\"C17H33N3O7S2\",\"molecularWeight\":\"455.6\",\"pubChemCID\":11597697,\"title\":\"Lisdexamfetamine Dimesylate\"},\"name\":\"Lisdexamfetamine Dimesylate\",\"role\":\"Active ingredient\"}],\"brandName\":\"Vyvanse\",\"categoryLabel\":\"Human Prescription Drug\",\"confidence\":\"officialLabel\",\"displayName\":\"Vyvanse\",\"genericName\":\"Lisdexamfetamine Dimesylate\",\"lookedUpAt\":\"2026-09-06T23:26:17.993Z\",\"otherIngredients\":[\"artificial strawberry flavor\",\"colloidal silicon dioxide\",\"croscarmellose sodium\",\"guar gum\",\"magnesium stearate\",\"mannitol\",\"microcrystalline cellulose\",\"sucralose\"],\"query\":\"Vyvanse\",\"sources\":[{\"name\":\"FDA Structured Product Label\",\"url\":\"https://open.fda.gov/apis/drug/label/\"},{\"name\":\"NIH PubChem — Lisdexamfetamine Dimesylate\",\"url\":\"https://pubchem.ncbi.nlm.nih.gov/compound/11597697\"}],\"summary\":\"Vyvanse is an FDA-labeled product containing Lisdexamfetamine Dimesylate.\"},\"quantityEvidenceID\":\"user-recorded-dose\",\"quantityWasUserAdjusted\":false,\"servingSize\":20,\"servingUnit\":\"mg\",\"source\":\"supplement\",\"trustMetadata\":{\"identityConfidence\":\"high\",\"identityEvidence\":\"nutritionLabel\",\"notes\":[\"Supplement label values retained with their product reference.\"],\"nutrientConfidence\":\"unknown\",\"nutrientEvidence\":\"unknown\",\"quantityConfidence\":\"medium\",\"quantityEvidence\":\"userEntered\"},\"updatedAt\":\"2026-09-12T19:44:20.113Z\",\"useCount\":0}",
      "consumed_timestamp": "2026-09-12T18:44:14.000Z",
      "timestamp_source": "item.consumedAt"
    }
  ]
}